{"id":43696,"date":"2015-09-17T11:25:58","date_gmt":"2015-09-17T16:25:58","guid":{"rendered":"https:\/\/content.findlaw-admin.com\/ability-legal\/contracts\/uncategorized\/stock-purchase-agreement-mti-technology-corp-caldera-systems.html"},"modified":"2015-09-17T11:25:58","modified_gmt":"2015-09-17T16:25:58","slug":"stock-purchase-agreement-mti-technology-corp-caldera-systems","status":"publish","type":"corporate_contracts","link":"https:\/\/corporate.findlaw.com\/contracts\/planning\/stock-purchase-agreement-mti-technology-corp-caldera-systems.html","title":{"rendered":"Stock Purchase Agreement &#8211; MTI Technology Corp., Caldera Systems Inc. and The Canopy Group Inc."},"content":{"rendered":"<pre>\n                            STOCK PURCHASE AGREEMENT\n\n\n\n                                      AMONG\n\n\n\n                           MTI TECHNOLOGY CORPORATION,\n                             a Delaware corporation\n\n\n\n                             CALDERA SYSTEMS, INC.,\n                               a Utah corporation\n\n\n                                       AND\n\n\n                             THE CANOPY GROUP, INC.,\n                               a Utah corporation\n\n\n\n\n\n\n                            Dated as of July 27, 1999\n\n\n   2\n                                TABLE OF CONTENTS\n\n<\/pre>\n<table>\n<caption>\n                                                                            Page<br \/>\n                                                                            &#8212;-<br \/>\n<s>                                                                         <c><\/p>\n<p>1.      DEFINITIONS &#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  1<\/p>\n<p>2.      PURCHASE AND SALE OF COMPANY SHARES AND SHAREHOLDER SHARES &#8230;&#8230;..  4<br \/>\n        2.1     Basic Transaction&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  4<br \/>\n        2.2     Purchase Price&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  4<br \/>\n        2.3     The Closing&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  5<br \/>\n        2.4     Deliveries at the Closing&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  5<\/p>\n<p>3.      REPRESENTATIONS AND WARRANTIES CONCERNING THE TRANSACTION &#8230;&#8230;&#8230;  5<br \/>\n        3.1     Representations and Warranties of the Company&#8230;&#8230;&#8230;&#8230;..  5<br \/>\n        3.2     Representations and Warranties of the Shareholder&#8230;&#8230;&#8230;.  16<br \/>\n        3.3     Representations and Warranties of the Buyer&#8230;&#8230;&#8230;&#8230;&#8230;.  17<\/p>\n<p>4.      PRE-CLOSING COVENANTS &#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  18<br \/>\n        4.1     General &#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  18<br \/>\n        4.2     Notices and Consents&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  18<br \/>\n        4.3     Operation of Business&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  18<br \/>\n        4.4     Preservation of Business&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  18<br \/>\n        4.5     Full Access&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  19<br \/>\n        4.6     Notice of Developments&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  19<br \/>\n        4.7     Exclusivity &#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  19<\/p>\n<p>5.      POST-CLOSING COVENANTS &#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  19<br \/>\n        5.1     General &#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  19<br \/>\n        5.2     Consultation&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  19<br \/>\n        5.3     Records&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  20<br \/>\n        5.4     Observer Rights&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  20<br \/>\n        5.5     Legends&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  20<br \/>\n        5.6     Distribution and License Agreement&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  21<\/p>\n<p>6.      CONDITIONS TO OBLIGATION TO CLOSE&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  21<br \/>\n        6.1     Conditions to Obligation of the Buyer&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  21<br \/>\n        6.2     Conditions to Obligation of the Company and Shareholder&#8230;.  22<\/p>\n<p>7.      REMEDIES FOR BREACHES OF THIS AGREEMENT&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  23<br \/>\n        7.1     Survival of Representations and Warranties&#8230;&#8230;&#8230;&#8230;&#8230;..  23<br \/>\n        7.2     Indemnification Provisions for Benefit of the Buyer&#8230;&#8230;..  23<br \/>\n        7.3     Indemnification Provisions for Benefit of the Company and<br \/>\n                Shareholder&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  24<br \/>\n        7.4     Matters Involving Third Parties&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  24<br \/>\n        7.5     Determination of Adverse Consequences&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  25<br \/>\n        7.6     Recoupment Against Purchase Price&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  26<br \/>\n        7.7     Other Indemnification Provisions&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  26<br \/>\n<\/c><\/s><\/caption>\n<\/table>\n<p>                                       i<br \/>\n   3<\/p>\n<table>\n<caption>\n                                                                            Page<br \/>\n                                                                            &#8212;-<br \/>\n<s>                                                                         <c><br \/>\n8.      TAX MATTERS&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  27<br \/>\n        8.1     Certain Taxes&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  27<\/p>\n<p>9.      TERMINATION&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  27<br \/>\n        9.1     Termination of Agreement&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  27<br \/>\n        9.2     Effect of Termination&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  27<\/p>\n<p>10.     MISCELLANEOUS &#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  28<br \/>\n        10.1    Press Releases and Public Announcements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  28<br \/>\n        10.2    No Third-Party Beneficiaries&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  28<br \/>\n        10.3    Entire Agreement&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  28<br \/>\n        10.4    Succession and Assignment&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  28<br \/>\n        10.5    Counterparts&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  28<br \/>\n        10.6    Headings&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  28<br \/>\n        10.7    Notices&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  28<br \/>\n        10.8    Governing Law&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  29<br \/>\n        10.9    Amendments and Waivers&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  29<br \/>\n        10.10   Severability&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  30<br \/>\n        10.11   Expenses&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  30<br \/>\n        10.12   Construction&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  30<br \/>\n        10.13   Incorporation of Exhibits, Annexes, and Schedules&#8230;&#8230;&#8230;.  30<br \/>\n        10.14   Specific Performance&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  30<br \/>\n        10.15   Submission to Jurisdiction&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  30<br \/>\n        10.16   Confidentiality&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  31<br \/>\n        10.17   California Corporate State Securities Law&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  31<br \/>\n<\/c><\/s><\/caption>\n<\/table>\n<p>                                       ii<br \/>\n   4<br \/>\nExhibit &#8216;A&#8217; &#8212; Historical Financial Statements<\/p>\n<p>Exhibit &#8216;B&#8217; &#8212; Form of Opinion of Counsel to the Company<\/p>\n<p>Exhibit &#8216;C&#8217; &#8212; Form of Investors Rights Agreement<\/p>\n<p>Exhibit &#8216;D&#8217; &#8212; Distribution and License Agreement<\/p>\n<p>Annex I &#8212; Disclosure Schedule of Exceptions to the Company and its Subsidiaries<br \/>\n              Representations and Warranties Concerning the Transaction<\/p>\n<p>Annex II &#8212; Exceptions to the Shareholder&#8217;s Representations and Warranties<br \/>\n               Concerning the Transaction<\/p>\n<p>Annex III &#8212; Exceptions to the Buyer&#8217;s Representations and Warranties Concerning<br \/>\n                the Transaction<\/p>\n<p>                                      iii<br \/>\n   5<br \/>\n                            STOCK PURCHASE AGREEMENT<\/p>\n<p>      Agreement entered into as of July 27, 1999, by and among MTI Technology<br \/>\nCorporation, a Delaware corporation (the &#8216;Buyer&#8217;), Caldera Systems, Inc., a Utah<br \/>\ncorporation (the &#8216;Company&#8217;), and The Canopy Group, Inc., a Utah corporation (the<br \/>\n&#8216;Shareholder&#8217;). The Buyer, the Company and the Shareholder are referred to<br \/>\ncollectively herein as the &#8216;Parties.&#8217;<\/p>\n<p>      A. The Company has 50,000,000 shares of authorized common stock,<br \/>\n16,000,000 of which are issued and outstanding.<\/p>\n<p>      B. The Shareholder owns sixteen million (16,000,000) shares of the<br \/>\noutstanding capital stock of the Company.<\/p>\n<p>      C. Buyer desires to acquire an aggregate of 25% of the issued and<br \/>\noutstanding capital stock of the Company, calculated immediately following the<br \/>\nclosing of the transactions contemplated hereunder.<\/p>\n<p>      Now, therefore, in consideration of the premises and the mutual promises<br \/>\nherein made, and in consideration of the representations, warranties, and<br \/>\ncovenants herein contained, the Parties agree as follows.<\/p>\n<p>      1 . Definitions.<\/p>\n<p>            &#8216;Accredited Investor&#8217; has the meaning set forth in Regulation D<br \/>\npromulgated under the Securities Act.<\/p>\n<p>            &#8216;Adverse Consequences&#8217; means all actions, suits, proceedings,<br \/>\nhearings, investigations, charges, complaints, claims, demands, injunctions,<br \/>\njudgments, orders, decrees, rulings, damages, dues, penalties, fines, costs,<br \/>\namounts paid in settlement, Liabilities, obligations, Taxes, liens, losses,<br \/>\nexpenses, and fees, including court costs and reasonable attorneys&#8217; fees and<br \/>\nexpenses.<\/p>\n<p>            &#8216;Affiliate&#8217; has the meaning set forth in Rule 12b-2 of the<br \/>\nregulations promulgated under the Securities Exchange Act.<\/p>\n<p>            &#8216;Affiliated Group&#8217; means any affiliated group within the meaning of<br \/>\nCode Section 1504(a) or any similar group defined under a similar provision of<br \/>\nstate, local or foreign law.<\/p>\n<p>            &#8216;Applicable Rate&#8217; means the prime rate of interest publicly<br \/>\nannounced from time to time by The Wall Street Journal plus 1% per annum.<\/p>\n<p>            &#8216;Basis&#8217; means any past or present fact, situation, circumstance,<br \/>\nstatus, condition, activity, practice, plan, occurrence, event, incident,<br \/>\naction, failure to act, or transaction that forms or could form the basis for<br \/>\nany specified consequence.<\/p>\n<p>            &#8216;Buyer&#8217; has the meaning set forth in the preface above.<\/p>\n<p>            &#8216;Closing&#8217; has the meaning set forth in Section 2.3 below.<\/p>\n<p>            &#8216;Closing Date&#8217; has the meaning set forth in Section 2.3 below.<\/p>\n<p>                                       1<br \/>\n   6<br \/>\n            &#8216;Code&#8217; means the Internal Revenue Code of 1986, as amended.<\/p>\n<p>            &#8216;Company&#8217; has the meaning set forth in the preface above.<\/p>\n<p>            &#8216;Company Share&#8217; means any of the 5,333,333 shares of Common Stock,<br \/>\nno par value, of the Company that the Buyer is purchasing from the Company as<br \/>\ncontemplated in this Agreement.<\/p>\n<p>            &#8216;Confidential Information&#8217; has the meaning set forth in Section<br \/>\n10.16 below.<\/p>\n<p>            &#8216;Deductible&#8217; has the meaning set forth in Section 7.2 below.<\/p>\n<p>            &#8216;Deferred Intercompany Transaction&#8217; has the meaning set forth in<br \/>\nReg. Section 1.1502-13.<\/p>\n<p>            &#8216;Disclosure Schedule&#8217; has the meaning set forth in Section 3.1<br \/>\nbelow.<\/p>\n<p>            &#8216;Distribution and License Agreement&#8217; shall mean the reciprocal<br \/>\nDistribution and License Agreement identified in Sections 5.6 and 6.1(k) below.<\/p>\n<p>            &#8216;Employee Benefit Plan&#8217; means any (a) nonqualified deferred<br \/>\ncompensation or retirement plan or arrangement which is an Employee Pension<br \/>\nBenefit Plan, (b) qualified defined contribution retirement plan or arrangement<br \/>\nwhich is an Employee Pension Benefit Plan, (c) qualified defined benefit<br \/>\nretirement plan or arrangement which is an Employee Pension Benefit Plan<br \/>\n(including any Multiemployer Plan), or (d) Employee Welfare Benefit Plan or<br \/>\nmaterial fringe benefit plan or program.<\/p>\n<p>            &#8216;Employee Pension Benefit Plan&#8217; has the meaning set forth in ERISA<br \/>\nSection 3(2).<\/p>\n<p>            &#8216;Employee Welfare Benefit Plan&#8217; has the meaning set forth in ERISA<br \/>\nSection 3(l).<\/p>\n<p>            &#8216;Environmental, Health, and Safety Requirements&#8217; shall mean all<br \/>\nfederal, state, local and foreign statutes, regulations, ordinances and other<br \/>\nprovisions having the force or effect of law, all judicial and administrative<br \/>\norders and determinations, all contractual obligations and all common law<br \/>\nconcerning public health and safety, worker health and safety, and pollution or<br \/>\nprotection of the environment, including without limitation all those relating<br \/>\nto the presence, use, production, generation, handling, transportation,<br \/>\ntreatment, storage, disposal, distribution, labeling, testing, processing,<br \/>\ndischarge, release, threatened release, control, or cleanup of any hazardous<br \/>\nmaterials, substances or wastes, chemical substances or mixtures, pesticides,<br \/>\npollutants, contaminants, toxic chemicals, petroleum products or byproducts,<br \/>\nasbestos, polychlorinated biphenyls, noise or radiation, each as amended and as<br \/>\nnow or hereafter in effect.<\/p>\n<p>            &#8216;ERISA&#8217; means the Employee Retirement Income Security Act of 1974,<br \/>\nas amended.<\/p>\n<p>            &#8216;Excess Loss Account&#8217; has the meaning set forth in Reg. Section<br \/>\n1.1502-19.<\/p>\n<p>            &#8216;Fiduciary&#8217; has the meaning set forth in ERISA Section 3(21).<\/p>\n<p>            &#8216;Financial Statement&#8217; has the meaning set forth in Section 3.1(h)<br \/>\nbelow.<\/p>\n<p>            &#8216;Final Distribution&#8217; has the meaning set forth in Section 2.2 below.<\/p>\n<p>                                       2<br \/>\n   7<br \/>\n            &#8216;GAAP&#8217; means United States generally accepted accounting principles<br \/>\nas in effect from time to time.<\/p>\n<p>            &#8216;Hart-Scott-Rodino Act&#8217; means the Hart-Scott-Rodino Antitrust<br \/>\nImprovements Act of 1976, as amended.<\/p>\n<p>            &#8216;Indemnified Party&#8217; has the meaning set forth in Section 7.4 below.<\/p>\n<p>            &#8216;Indemnifying Party&#8217; has the meaning set forth in Section 7.4 below.<\/p>\n<p>            &#8216;Informed Party&#8217; has the meaning set forth in Section 10.16 below.<\/p>\n<p>            &#8216;Informing Party&#8217; has the meaning set forth in Section 10.16<br \/>\nbelow.<\/p>\n<p>            &#8216;Initial Distribution&#8217; has the meaning set forth in Section 2.2<br \/>\nbelow.<\/p>\n<p>            &#8216;Intellectual Property&#8217; means (a) patent rights, patent<br \/>\napplications, and patents, and reissuances, continuations,<br \/>\ncontinuations-in-part, divisions, extensions, and reexaminations thereof, (b)<br \/>\ntrademarks, service marks, and trade names, and applications to register<br \/>\ntrademarks or service marks, and registrations of trademarks and service marks,<br \/>\n(c) copyrights, and all applications to register copyrights, and all<br \/>\nregistrations of copyrights, and renewals thereof, (d) trade secrets and other<br \/>\nproprietary rights, and (e) any other intellectual property.<\/p>\n<p>            &#8216;Investors Rights Agreement&#8217; means an Investors Rights Agreement<br \/>\nbetween the Company, the Shareholder and Buyer substantially in the form of<br \/>\nExhibit &#8216;C.&#8217;<\/p>\n<p>            &#8216;Knowledge&#8217; means actual knowledge after reasonable investigation;<br \/>\nprovided, however, that there is no obligation to conduct intellectual property<br \/>\nsearches or other intellectual property investigations outside the Company and<br \/>\nits subsidiaries.<\/p>\n<p>            &#8216;Liability&#8217; means any liability (whether known or unknown, whether<br \/>\nasserted or unasserted, whether absolute or contingent, whether accrued or<br \/>\nunaccrued, whether liquidated or unliquidated, and whether due or to become<br \/>\ndue), including any liability for Taxes.<\/p>\n<p>            &#8216;Millennial Dates&#8217; has the meaning set forth in Section 3.1(m)(vi)<br \/>\nbelow.<\/p>\n<p>            &#8216;Most Recent Balance Sheet&#8217; means the balance sheet at June 23,<br \/>\n1999.<\/p>\n<p>            &#8216;Multiemployer Plan&#8217; has the meaning set forth in ERISA Section<br \/>\n3(37).<\/p>\n<p>            &#8216;Ordinary Course of Business&#8217; means the ordinary course of business<br \/>\nconsistent with past or current custom and practice.<\/p>\n<p>            &#8216;Party&#8217; has the meaning set forth in the preface above.<\/p>\n<p>            &#8216;PBGC&#8217; means the Pension Benefit Guaranty Corporation.<\/p>\n<p>            &#8216;Person&#8217; means an individual, a partnership, a corporation, an<br \/>\nassociation, a joint stock company, a trust, a joint venture, an unincorporated<br \/>\norganization, or a governmental entity (or any department, agency, or political<br \/>\nsubdivision thereof).<\/p>\n<p>            &#8216;Products&#8217; has the meaning set forth in Section 3.1(m)(vi) below.<\/p>\n<p>            &#8216;Purchase Price&#8217; has the meaning set forth in Section 2.2 below.<\/p>\n<p>            &#8216;Reduction Notice&#8217; has the meaning set forth in Section 7.6(a)<br \/>\nbelow.<\/p>\n<p>                                       3<br \/>\n   8<br \/>\n            &#8216;Reduction Disputing Notice&#8217; has the meaning set forth in Section<br \/>\n7.6(b) below.<\/p>\n<p>            &#8216;Reportable Event&#8217; has the meaning set forth in ERISA Section 4043.<\/p>\n<p>            &#8216;Securities Act&#8217; means the Securities Act of 1933, as amended.<\/p>\n<p>            &#8216;Securities Exchange Act&#8217; means the Securities Exchange Act of 1934,<br \/>\nas amended.<\/p>\n<p>            &#8216;Security Interest&#8217; means any mortgage, pledge, lien, encumbrance,<br \/>\ncharge, or other security interest, other than (a) mechanic&#8217;s, materialmen&#8217;s,<br \/>\nand similar liens, (b) liens for Taxes not yet due and payable or for Taxes that<br \/>\nthe taxpayer is contesting in good faith through appropriate proceedings, (c)<br \/>\npurchase money liens and liens securing rental payments under capital lease<br \/>\narrangements, and (d) other liens arising in the Ordinary Course of Business and<br \/>\nnot incurred in connection with the borrowing of money.<\/p>\n<p>            &#8216;Subsidiary&#8217; means any corporation or other entity with respect to<br \/>\nwhich a specified Person (or a Subsidiary thereof) owns a majority of the common<br \/>\nstock or has the power to vote or direct the voting of sufficient securities to<br \/>\nelect a majority of the directors or similar governing body (e.g. managers).<\/p>\n<p>            &#8216;Tax&#8217; means any federal, state, local, or foreign income, gross<br \/>\nreceipts, license, payroll, employment, excise, severance, stamp, occupation,<br \/>\npremium, windfall profits, environmental (including taxes under Code Section<br \/>\n59A), customs duties, capital stock, franchise, profits, withholding, social<br \/>\nsecurity (or similar), unemployment, disability, real property, personal<br \/>\nproperty, sales, use, transfer, registration, value added, alternative or add-on<br \/>\nminimum, estimated, or other tax of any kind whatsoever, including any interest,<br \/>\npenalty, or addition thereto, whether disputed or not.<\/p>\n<p>            &#8216;Tax Return&#8217; means any return, declaration, report, claim for<br \/>\nrefund, or information return or statement relating to Taxes, including any<br \/>\nschedule or attachment thereto, and including any amendment thereof.<\/p>\n<p>            &#8216;Third Party Claim&#8217; has the meaning set forth in Section 7.4 below.<\/p>\n<p>            &#8216;Transactional Agreements&#8217; means this Agreement and the Investors<br \/>\nRights Agreement.<\/p>\n<p>            &#8216;Year 2000 Compliant&#8217; has the meaning set forth in Section<br \/>\n3.1(m)(vi) below.<\/p>\n<p>      2. Purchase and Sale of Company Shares and Shareholder Shares.<\/p>\n<p>            2.1 Basic Transaction.<\/p>\n<p>            On and subject to the terms and conditions of this Agreement, the<br \/>\nBuyer agrees to purchase from the Company, and the Company agrees to sell to the<br \/>\nBuyer, an aggregate of 5,333,333 Company Shares for the consideration specified<br \/>\nbelow in this Section 2.<\/p>\n<p>            2.2 Purchase Price.<\/p>\n<p>            The Buyer agrees to pay to the Company an aggregate of Six Million<br \/>\nDollars ($6,000,000) in consideration for the Company Shares (the &#8216;Purchase<br \/>\nPrice&#8217;). The Purchase Price shall be delivered by the Buyer to the Company in<br \/>\nthree distributions. The Buyer shall deliver<\/p>\n<p>                                       4<br \/>\n   9<br \/>\nThree Million Dollars ($3,000,000) to the Company at the Closing (hereinafter<br \/>\nthe &#8216;Initial Distribution&#8217;). On the later of (a) the resolution of any pending<br \/>\nrecoupment pursuant to Section 7.6 or (b) six (6) months after the Closing, the<br \/>\nBuyer shall deliver to the Company One Million Five Hundred Thousand Dollars<br \/>\n($1,500,000), plus interest accrued thereon at the Applicable Rate, and less any<br \/>\namounts due Buyer under Section 7 (hereinafter the &#8216;Second Distribution&#8217;). On<br \/>\nthe later of (y) the resolution of any pending recoupment pursuant to Section<br \/>\n7.6 or (z) twelve (12) months after the Closing, the Buyer shall deliver to the<br \/>\nCompany One Million Five Hundred Thousand Dollars ($1,500,000), plus interest<br \/>\naccrued thereon at the Applicable Rate, and less any amounts due Buyer under<br \/>\nSection 7, to the Company (hereinafter the &#8216;Final Distribution&#8217;).<\/p>\n<p>            2.3 The Closing.<\/p>\n<p>            The closing of the transactions contemplated by this Agreement (the<br \/>\n&#8216;Closing&#8217;) shall take place at the offices of Morrison &amp; Foerster LLP at 19900<br \/>\nMacArthur Boulevard, Irvine, California, commencing at 9:00 a.m. local time on<br \/>\nthe later of August 6, 1999 or the second business day following the<br \/>\nsatisfaction or waiver of all conditions to the obligations of the Parties to<br \/>\nconsummate the transactions contemplated hereby (other than conditions with<br \/>\nrespect to actions the respective Parties will take at the Closing itself) or<br \/>\nsuch other date as the Buyer and the Company may mutually determine (the<br \/>\n&#8216;Closing Date&#8217;).<\/p>\n<p>            2.4 Deliveries at the Closing.<\/p>\n<p>            At the Closing, (i) the Company will deliver to the Buyer the<br \/>\nvarious certificates, instruments, and documents referred to in Section 6.1<br \/>\nbelow, (ii) the Buyer will deliver to the Company the various certificates,<br \/>\ninstruments, and documents referred to in Section 6.2 below, (iii) the Company<br \/>\nwill deliver to the Buyer stock certificates representing all of the Company<br \/>\nShares, and (iv) the Buyer will deliver to the Company the consideration<br \/>\nspecified in Section 2.2 above.<\/p>\n<p>      3. Representations and Warranties Concerning the Transaction.<\/p>\n<p>            3.1 Representations and Warranties of the Company and its<br \/>\nSubsidiaries.<\/p>\n<p>            The Company represents and warrants to the Buyer that the statements<br \/>\ncontained in this Section 3 are correct and complete as of the date of this<br \/>\nAgreement and will be correct and complete as of the Closing Date (as though<br \/>\nmade then and as though the Closing Date were substituted for the date of this<br \/>\nAgreement throughout this Section 3), except as set forth in the disclosure<br \/>\nschedule delivered by the Company to the Buyer on the date hereof and initialed<br \/>\nby the Parties (the &#8216;Disclosure Schedule&#8217;), attached hereto as Annex I. Nothing<br \/>\nin the Disclosure Schedule shall be deemed adequate to disclose an exception to<br \/>\na representation or warranty made herein, however, unless the Disclosure<br \/>\nSchedule identifies the exception and the relevant facts with reasonable detail.<br \/>\nWithout limiting the generality of the foregoing, the mere listing (or inclusion<br \/>\nof a copy) of a document or other item shall not be deemed adequate to disclose<br \/>\nan exception to a representation or warranty made herein (unless the<br \/>\nrepresentation or warranty has to do with the existence of the document or other<br \/>\nitem itself). The Disclosure Schedule will be arranged in paragraphs<br \/>\ncorresponding to the lettered and numbered paragraphs contained in this Section<br \/>\n3.<\/p>\n<p>                  (a) Organization, Qualification and Corporate Power. Each of<br \/>\nthe Company and its Subsidiaries is a corporation duly organized, validly<br \/>\nexisting, and in good<\/p>\n<p>                                       5<br \/>\n   10<br \/>\nstanding under the laws of the jurisdiction of its incorporation. Each of the<br \/>\nCompany and its Subsidiaries is duly authorized to conduct business and is in<br \/>\ngood standing under the laws of each jurisdiction where such qualification is<br \/>\nrequired (except for any such jurisdiction in which the failure to be so<br \/>\nqualified, individually or in the aggregate, would not have a material adverse<br \/>\neffect on the Company or any of its Subsidiaries). Each of the Company and its<br \/>\nSubsidiaries has full corporate power and authority and all licenses, permits,<br \/>\nand authorizations necessary to carry on the businesses in which it is engaged<br \/>\nand in which it presently proposes to engage and to own and use the properties<br \/>\nowned and used by it, except for any such licenses, permits and authorizations,<br \/>\nthe failure of which to obtain, individually or in the aggregate, would not have<br \/>\na material adverse effect on the Company or any of its Subsidiaries. The Company<br \/>\nhas delivered to the Buyer correct and complete copies of the charter and bylaws<br \/>\nof each of the Company and its Subsidiaries (as amended to date). The minute<br \/>\nbooks (containing the records of meetings of the stockholders, the board of<br \/>\ndirectors, and any committees of the board of directors), the stock certificate<br \/>\nbooks, and the stock record books of each of the Company and its Subsidiaries<br \/>\nare correct and complete. None of the Company or any of its Subsidiaries is in<br \/>\ndefault under or in violation of any provision of its charter or bylaws.<\/p>\n<p>                  (b) Authorization of Transaction. The Company has full<br \/>\ncorporate power and authority to execute and deliver this Agreement, the<br \/>\nInvestors Rights Agreement and the Distribution and License Agreement and to<br \/>\nperform its obligations hereunder and thereunder. Each of the Transactional<br \/>\nAgreements constitutes the valid and legally binding obligation of the Company,<br \/>\nenforceable in accordance with their respective terms and conditions. Except for<br \/>\nfilings that may be required by applicable state securities laws, the Company<br \/>\nneed not give any notice to, make any filing with, or obtain any authorization,<br \/>\nconsent, or approval of any government or governmental agency in order to<br \/>\nconsummate the transactions contemplated by the Transactional Agreements.<\/p>\n<p>                  (c) Noncontravention. Neither the execution and the delivery<br \/>\nof the Transactional Agreements, nor the consummation of the transactions<br \/>\ncontemplated hereby and thereby, will (i) violate any constitution, statute,<br \/>\nregulation, rule, injunction, judgment, order, decree, ruling, charge, or other<br \/>\nrestriction of any government, governmental agency, or court to which any of the<br \/>\nCompany and its Subsidiaries is subject or any provision of the charter or<br \/>\nbylaws of any of the Company and its Subsidiaries, or (ii) conflict with, result<br \/>\nin a breach of, constitute a default under, result in the acceleration of,<br \/>\ncreate in any party the right to accelerate, terminate, modify, or cancel, or<br \/>\nrequire any notice under any agreement, contract, lease, license, instrument, or<br \/>\nother arrangement to which any of the Company or any of its Subsidiaries is a<br \/>\nparty or by which it is bound or to which any of their respective assets are<br \/>\nsubject (or result in the imposition of any Security Interest upon any of their<br \/>\nrespective assets).<\/p>\n<p>                  (d) Brokers&#8217; Fees. The Company has no Liability or obligation<br \/>\nto pay any fees or commissions to any broker, finder, or agent with respect to<br \/>\nthe transactions contemplated by this Agreement for which the Buyer could become<br \/>\nliable or obligated.<\/p>\n<p>                  (e) Company Shares. The Company Shares have been duly and<br \/>\nvalidly authorized and at the Closing will be duly and validly issued,<br \/>\nnonassessable and fully paid, free and clear of any restrictions on transfer<br \/>\n(other than any restrictions under the Securities Act and state securities<br \/>\nlaws), Taxes, Security Interests, options, warrants, purchase rights,<br \/>\ncontracts,<\/p>\n<p>                                       6<br \/>\n   11<br \/>\ncommitments, equities, claims, and demands, except as provided in the Investors<br \/>\nRights Agreement.<\/p>\n<p>                  (f) Title to Assets. The Company and its Subsidiaries have<br \/>\ngood and marketable title to, or a valid leasehold or license interest in, or<br \/>\nother right to use, the properties and assets used by them, located on their<br \/>\npremises, or shown on the Most Recent Balance Sheet or acquired after the date<br \/>\nthereof, free and clear of all Security Interests, except for properties and<br \/>\nassets disposed of in the Ordinary Course of Business since the date of the Most<br \/>\nRecent Balance Sheet. This subsection (f) shall not apply to Intellectual<br \/>\nProperty or any infringement, misappropriation or violation of Intellectual<br \/>\nProperty. Any warranty of the Company concerning Intellectual Property is<br \/>\nlimited to subsections (m) and (p) below.<\/p>\n<p>                  (g) Subsidiaries. Section 3.1(g) of the Disclosure Schedule<br \/>\nsets forth for each Subsidiary of the Company (i) its name and jurisdiction of<br \/>\nincorporation or organization, (ii) the number of shares of authorized capital<br \/>\nstock of each class of its capital stock, (iii) the number of issued and<br \/>\noutstanding shares of each class of its capital stock, the names of the holders<br \/>\nthereof, and the number of shares held by each such holder, and (iv) the number<br \/>\nof shares of its capital stock held in treasury. All of the issued and<br \/>\noutstanding shares of capital stock of each Subsidiary of the Company have been<br \/>\nduly authorized and are validly issued, fully paid, and nonassessable. The<br \/>\nCompany or its Subsidiary holds of record and owns beneficially the number of<br \/>\nshares of each Subsidiary of the Company as set forth in Section 3.1(g) of the<br \/>\nDisclosure Schedule, free and clear of any restrictions on transfer (other than<br \/>\nrestrictions under the Securities Act and state securities laws), Taxes,<br \/>\nSecurity Interests, options, warrants, purchase rights, contracts, commitments<br \/>\nequities, claims, and demands. There are no outstanding or authorized options,<br \/>\nwarrants, purchase rights, subscription rights, conversion rights, exchange<br \/>\nrights, or other contracts or commitments that could require any of the Company<br \/>\nand its Subsidiaries to sell, transfer, or otherwise dispose of any capital<br \/>\nstock of any of its Subsidiaries or that could require any Subsidiary of the<br \/>\nCompany to issue, sell, or otherwise cause to become outstanding any of its own<br \/>\ncapital stock. There are no voting trusts, proxies, or other agreements or<br \/>\nunderstandings with respect to the voting of any capital stock of any Subsidiary<br \/>\nof the Company. None of the Company and its Subsidiaries controls directly or<br \/>\nindirectly or has any direct or indirect equity participation in any<br \/>\ncorporation, partnership, trust, or other business association which is not a<br \/>\nSubsidiary of the Company.<\/p>\n<p>                  (h) Financial Statements. Attached hereto as Exhibit &#8216;A&#8217; are<br \/>\nthe following financial statements (collectively the &#8216;Financial Statements&#8217;):<br \/>\n(i) unaudited consolidated monthly income statement for November 1998 through<br \/>\nApril 1999, and the individual monthly statements for such quarter, for the<br \/>\nCompany and its Subsidiaries; (ii) unaudited balance sheets as of June 23, 1999<br \/>\nfor the Company and its Subsidiaries; and (iii) the Company&#8217;s Business Plan<br \/>\ncovering operations from November 1, 1999 through October 31, 2001. The<br \/>\nFinancial Statements (including the notes thereto) have been prepared in<br \/>\naccordance with GAAP applied on a consistent basis throughout the periods<br \/>\ncovered thereby, and except as to the projection and Business Plan, present<br \/>\nfairly the financial condition of the Company and its Subsidiaries as of such<br \/>\ndates and the results of operations of the Company and its Subsidiaries for such<br \/>\nperiods, are correct and complete, and are consistent with the books and records<br \/>\nof the Company and its Subsidiaries (which books and records are correct and<br \/>\ncomplete), subject to normal year-end adjustments (which<\/p>\n<p>                                       7<br \/>\n   12<br \/>\nwill not be material individually or in the aggregate) and lack footnotes and<br \/>\nother presentation items.<\/p>\n<p>                  (i) Events Subsequent to Most Recent Balance Sheet. Since the<br \/>\ndate of the Most Recent Balance Sheet, there has not been any adverse change in<br \/>\nthe business, financial condition, operations, results of operations, or future<br \/>\nprospects of any of the Company and its Subsidiaries. Without limiting the<br \/>\ngenerality of the foregoing, since that date:<\/p>\n<p>                        (i) none of the Company or its Subsidiaries has sold,<br \/>\n      leased, transferred, or assigned any of its assets, tangible or<br \/>\n      intangible, other than in the Ordinary Course of Business and in the<br \/>\n      reasonable business judgment of the Company for a fair consideration;<\/p>\n<p>                        (ii) none of the Company or its Subsidiaries has entered<br \/>\n      into any agreement, contract, lease, or license (or series of related<br \/>\n      agreements, contracts, leases, and licenses) either involving more than<br \/>\n      $100,000 or outside the Ordinary Course of Business;<\/p>\n<p>                        (iii) no party (including any of the Company and its<br \/>\n      Subsidiaries) has accelerated, terminated, modified, or cancelled any<br \/>\n      agreement, contract, lease, or license (or series of related agreements,<br \/>\n      contracts, leases, and licenses) involving more than $100,000 to which any<br \/>\n      of the Company and its Subsidiaries is a party or by which any of them is<br \/>\n      bound;<\/p>\n<p>                        (iv) none of the Company or its Subsidiaries has imposed<br \/>\n      any Security Interest upon any of its assets, tangible or intangible;<\/p>\n<p>                        (v) none of the Company or its Subsidiaries has made any<br \/>\n      capital expenditure (or series of related capital expenditures) either<br \/>\n      involving more than $100,000 or outside the Ordinary Course of Business;<\/p>\n<p>                        (vi) none of the Company or its Subsidiaries has made<br \/>\n      any capital investment in, any loan to, or any acquisition of the<br \/>\n      securities or assets of, any other Person (or series of related capital<br \/>\n      investments, loans, and acquisitions) either involving more than $100,000<br \/>\n      or outside the Ordinary Course of Business;<\/p>\n<p>                        (vii) none of the Company or its Subsidiaries has issued<br \/>\n      any note, bond, or other debt security or created, incurred, assumed, or<br \/>\n      guaranteed any indebtedness for borrowed money or capitalized lease<br \/>\n      obligation either involving more than $250,000 singly or $1,000,000 in the<br \/>\n      aggregate;<\/p>\n<p>                        (viii) none of the Company or its Subsidiaries has<br \/>\n      delayed or postponed the payment of accounts payable and other Liabilities<br \/>\n      outside the Ordinary Course of Business;<\/p>\n<p>                        (ix) none of the Company or its Subsidiaries has<br \/>\n      cancelled, compromised, waived, or released any right or claim (or series<br \/>\n      of related rights and claims) either involving more than $100,000 or<br \/>\n      outside the Ordinary Course of Business;<\/p>\n<p>                        (x) except as set forth in Section 3.1(i)(x) of the<br \/>\n      Disclosure Schedule, none of the Company or its Subsidiaries has granted<br \/>\n      any license or sublicense of any rights under or with respect to any<br \/>\n      Intellectual Property;<\/p>\n<p>                                       8<br \/>\n   13<br \/>\n                        (xi) there has been no change made or authorized in the<br \/>\n      charter or bylaws of any of the Company and its Subsidiaries;<\/p>\n<p>                        (xii) none of the Company or its Subsidiaries has<br \/>\n      experienced any material damage, destruction, or loss (whether or not<br \/>\n      covered by insurance) to its property;<\/p>\n<p>                        (xiii) none of the Company or its Subsidiaries has made<br \/>\n      any loan to, or entered into any other transaction with, any of its<br \/>\n      directors, officers, and employees outside the Ordinary Course of<br \/>\n      Business;<\/p>\n<p>                        (xiv) except as set forth on Section 3.1(i)(xiv) of the<br \/>\n      Disclosure Schedule, none of the Company or its Subsidiaries has entered<br \/>\n      into any employment contract or collective bargaining agreement, written<br \/>\n      or oral, or modified the terms of any existing such contract or agreement;<\/p>\n<p>                        (xv) none of the Company or its Subsidiaries has granted<br \/>\n      any increase in the base compensation of any of its directors, officers,<br \/>\n      and employees outside the Ordinary Course of Business;<\/p>\n<p>                        (xvi) none of the Company or its Subsidiaries has<br \/>\n      adopted, amended, modified, or terminated any bonus, profit-sharing,<br \/>\n      incentive, severance, or other plan, contract, or commitment for the<br \/>\n      benefit of any of its directors, officers, and employees (or taken any<br \/>\n      such action with respect to any other Employee Benefit Plan);<\/p>\n<p>                        (xvii) none of the Company or its Subsidiaries has made<br \/>\n      any other change in employment terms for any of its directors, officers,<br \/>\n      and employees outside the Ordinary Course of Business;<\/p>\n<p>                        (xviii) none of the Company or its Subsidiaries has made<br \/>\n      or pledged to make any charitable or other capital contribution outside<br \/>\n      the Ordinary Course of Business;<\/p>\n<p>                        (xix) there has not been any other occurrence, event,<br \/>\n      incident, action, failure to act, or transaction outside the Ordinary<br \/>\n      Course of Business involving any of the Company and its Subsidiaries; and<\/p>\n<p>                        (xx) none of the Company or its Subsidiaries has<br \/>\n      committed to any of the foregoing.<\/p>\n<p>                  (j) Undisclosed Liabilities. None of the Company or its<br \/>\nSubsidiaries has any Liability (and there is no Basis for any present or future<br \/>\naction, suit, proceeding, hearing, investigation, charge, complaint, claim, or<br \/>\ndemand against any of them giving rise to any Liability), except for (i)<br \/>\nLiabilities set forth on the face of the Most Recent Balance Sheet (rather than<br \/>\nin any notes thereto) and (ii) Liabilities which have arisen after the date of<br \/>\nthe Most Recent Balance Sheet in the Ordinary Course of Business (none of which<br \/>\nresults from, arises out of, relates to, is in the nature of, or was caused by<br \/>\nany breach of contract, breach of warranty, tort, infringement, or violation of<br \/>\nlaw).<\/p>\n<p>                  (k) Legal Compliance. Each of the Company, its Subsidiaries,<br \/>\nand their respective predecessors and Affiliates, has complied with all<br \/>\napplicable laws (including rules, regulations, codes, plans, injunctions,<br \/>\njudgments, orders, decrees, rulings, and charges thereunder)<\/p>\n<p>                                       9<br \/>\n   14<br \/>\nof federal, state, local, and foreign governments (and all agencies thereof),<br \/>\nand no action, suit, proceeding, hearing, investigation, charge, complaint,<br \/>\nclaim, demand, or notice has been filed or commenced against any of them<br \/>\nalleging any failure so to comply.<\/p>\n<p>                  (1) Tax Matters. The Company and its Subsidiaries have filed<br \/>\nall Tax Returns that each was required to file. All such Tax Returns were<br \/>\ncorrect and complete in all respects. All Taxes owed by the Company and any of<br \/>\nits Subsidiaries (whether or not shown on any Tax Return) have been paid.<br \/>\nNeither of the Company nor any of its Subsidiaries currently is the beneficiary<br \/>\nof any extension of time within which to file any Tax Return. No claim has ever<br \/>\nbeen made by an authority in a jurisdiction where the Company or any of its<br \/>\nSubsidiaries does not file Tax Returns that the Company or such Subsidiary is or<br \/>\nmay be subject to taxation by that jurisdiction. There are no Security Interests<br \/>\non any of the assets of the Company or any of its Subsidiaries imposed by any<br \/>\ntax authority.<\/p>\n<p>                        (i) Each of the Company and its Subsidiaries has<br \/>\n      withheld and paid all Taxes required to have been withheld and paid in<br \/>\n      connection with amounts paid or owing to any employee, independent<br \/>\n      contractor, creditor, stockholder, or other third party.<\/p>\n<p>                        (ii) Neither the Company nor any director or officer (or<br \/>\n      employee responsible for Tax matters) of any of the Company and its<br \/>\n      Subsidiaries expects any authority to assess any additional Taxes for any<br \/>\n      period for which Tax Returns have been filed. There is no dispute or claim<br \/>\n      concerning any Tax Liability of any of the Company and its Subsidiaries<br \/>\n      either (A) claimed or raised by any authority in writing or (B) as to<br \/>\n      which any of the Shareholder, the Company and the directors and officers<br \/>\n      (and employees responsible for Tax matters) of the Company and its<br \/>\n      Subsidiaries has Knowledge based upon personal contact with any agent of<br \/>\n      such authority.<\/p>\n<p>                        (iii) The Company has not waived any statute of<br \/>\n      limitations in respect of Taxes or agreed to any extension of time with<br \/>\n      respect to a Tax assessment or deficiency.<\/p>\n<p>                        (iv) Neither of the Company nor any of its Subsidiaries<br \/>\n      has filed a consent under Code Section 341(f) concerning collapsible<br \/>\n      corporations. Neither of the Company nor any of its Subsidiaries has made<br \/>\n      any payments, is obligated to make any payments, or is a party to any<br \/>\n      agreement that under certain circumstances could obligate it to make any<br \/>\n      payments that will not be deductible under Code Sections 162(m) or 280G.<br \/>\n      Neither of the Company nor any of its Subsidiaries has been a United<br \/>\n      States real property holding corporation within the meaning of Code<br \/>\n      Section 897(c)(2) during the applicable period specified in Code Section<br \/>\n      897(c)(1)(A)(ii). The Company and each of its Subsidiaries has disclosed<br \/>\n      on its federal income Tax Returns all positions taken therein that could<br \/>\n      give rise to a substantial understatement of federal income Tax within the<br \/>\n      meaning of Code Section 6662. Neither of the Company nor any of its<br \/>\n      Subsidiaries is a party to any Tax allocation or sharing agreement.<br \/>\n      Neither of the Company nor any of its Subsidiaries (A) has been a member<br \/>\n      of an Affiliated Group filing a consolidated federal income Tax Return<br \/>\n      (other than a group the common parent of which was the Shareholder) and<br \/>\n      (B) does not have any Liability for the Taxes of any Person (other than<br \/>\n      the Company or any of its Subsidiaries) under Reg. Section 1.1502-6 (or<br \/>\n      any similar provision of state, local, or<\/p>\n<p>                                       10<br \/>\n   15<br \/>\n      foreign law), as a transferee or successor, by contract, or otherwise. The<br \/>\n      Company and each of its Subsidiaries is in compliance with the terms and<br \/>\n      conditions of any applicable Tax exemptions, agreements or orders of any<br \/>\n      government to which it may be subject or which it may have claimed, and<br \/>\n      the transaction contemplated by this Agreement will not have any adverse<br \/>\n      effect on such compliance.<\/p>\n<p>                        (v) The unpaid Taxes of the Company and its Subsidiaries<br \/>\n      (A) did not, as of the date of the Most Recent Balance Sheet, exceed the<br \/>\n      reserve for Tax Liability (rather than any reserve for deferred Taxes<br \/>\n      established to reflect timing differences between book and Tax income) set<br \/>\n      forth on the face of the Most Recent Balance Sheet (rather than in any<br \/>\n      notes thereto) and (B) do not exceed that reserve as adjusted for the<br \/>\n      passage of time through the Closing Date in accordance with the past<br \/>\n      custom and practice of the Company and its Subsidiaries in filing their<br \/>\n      Tax Returns.<\/p>\n<p>                  (m) Intellectual Property. The Company, its Subsidiaries and<br \/>\ntheir products have not infringed and do not infringe the copyrights of any<br \/>\nthird party. Neither the Company nor its Subsidiaries has misappropriated or is<br \/>\nmisappropriating any trade secrets or proprietary confidential information of<br \/>\nany third party, and the products of the Company and its Subsidiaries do not<br \/>\ninclude or embody any trade secret or proprietary confidential information<br \/>\nmisappropriated by the Company or its Subsidiaries from any Third Party. To the<br \/>\nKnowledge of the Company, each of the Company and its Subsidiaries and their<br \/>\nrespective products have not infringed and do not infringe any patents,<br \/>\ntrademarks, service marks, or trade names of any third party. Each item of<br \/>\nIntellectual Property owned by or licensed to the Company and its Subsidiaries<br \/>\nimmediately prior to the Closing hereunder will be owned by or licensed to the<br \/>\nCompany and the Subsidiary on identical terms and conditions immediately<br \/>\nsubsequent to the Closing hereunder (i.e., identical to any applicable terms and<br \/>\nconditions immediately prior to the Closing).<\/p>\n<p>                        (i) None of the Company or its Subsidiaries or their<br \/>\n      directors and officers (and employees with responsibility for Intellectual<br \/>\n      Property matters) has ever received any charge, complaint, claim, demand,<br \/>\n      or notice alleging any such infringement, misappropriation, or violation<br \/>\n      of Intellectual Property (including any claim that the Company and its<br \/>\n      Subsidiaries must license or refrain from using any Intellectual Property<br \/>\n      rights of any third party). To the Knowledge of the Company and its<br \/>\n      Subsidiaries and the directors and officers (and employees with<br \/>\n      responsibility for Intellectual Property matters) of the Company and its<br \/>\n      Subsidiaries, no third party has infringed, misappropriated, or otherwise<br \/>\n      violated any Intellectual Property rights of the Company and its<br \/>\n      Subsidiaries.<\/p>\n<p>                        (ii) Section 3.1(m) of the Disclosure Schedule<br \/>\n      identifies (a) each patent which has been issued or assigned to the<br \/>\n      Company and its Subsidiaries, (b) each pending patent application which<br \/>\n      has been filed by or for the Company and its Subsidiaries, (c) each<br \/>\n      trademark or service mark registration issued or assigned to the Company<br \/>\n      and its Subsidiaries, (d) each pending trademark or service mark<br \/>\n      application which has been filed by or for the Company and its<br \/>\n      Subsidiaries, (e) each copyright registration issued or assigned to the<br \/>\n      Company and its Subsidiaries, (f) each pending copyright application which<br \/>\n      has been filed by or for the Company and its Subsidiaries, and (g) each<br \/>\n      license which the Company and its Subsidiaries has granted to any third<br \/>\n      party with respect to any of the Company&#8217;s Intellectual Property excluding<br \/>\n      licenses to end users of Company products<\/p>\n<p>                                       11<br \/>\n   16<br \/>\n      granted in the Ordinary Course of Business. The Company has delivered to<br \/>\n      the Buyer correct and complete copies of all such patents, registrations,<br \/>\n      applications, and licenses (as amended to date). Section 3.1(m) of the<br \/>\n      Disclosure Schedule also identifies each trade name and each unregistered<br \/>\n      trademark or service mark used by any of the Company and its Subsidiaries<br \/>\n      in connection with any of their businesses. With respect to each patent,<br \/>\n      application, and registration (each an &#8216;item&#8217;) identified in Section<br \/>\n      3.1(m) of the Disclosure Schedule:<\/p>\n<p>                              (A) the Company and its Subsidiaries possess all<br \/>\n            right, title, and interest in and to the item, free and clear of any<br \/>\n            Security Interest, license, or other restriction;<\/p>\n<p>                              (B) the item is not subject to any outstanding<br \/>\n            injunction, judgment, order, decree, ruling, or charge;<\/p>\n<p>                              (C) no action, suit, proceeding, hearing,<br \/>\n            investigation, charge, complaint, claim, or demand is pending or, to<br \/>\n            the Knowledge of any of the Company, the directors and officers (and<br \/>\n            employees with responsibility for Intellectual Property matters) of<br \/>\n            the Company and its Subsidiaries, is threatened which challenges the<br \/>\n            legality, validity, enforceability, use, or ownership of the item;<br \/>\n            and<\/p>\n<p>                              (D) none of the Company and its Subsidiaries has<br \/>\n            ever agreed to indemnify any Person for or against any interference,<br \/>\n            infringement, misappropriation, or other conflict with respect to<br \/>\n            the item.<\/p>\n<p>                        (iii) Section 3.1(m) of the Disclosure Schedule<br \/>\n      identifies each item of Intellectual Property that any third party owns<br \/>\n      and licenses to any of the Company and its Subsidiaries, excluding<br \/>\n      licenses to commercially available software products (e.g., Windows,<br \/>\n      Microsoft Office, etc.) used by any of the Company and its Subsidiaries as<br \/>\n      an end user. The Company has delivered to the Buyer correct and complete<br \/>\n      copies of all agreements applicable to such licenses (as amended to date).<br \/>\n      The term &#8216;license&#8217; is intended to include &#8216;sublicense.&#8217; With respect to<br \/>\n      each such license and agreement required to be identified in Section<br \/>\n      3.1(m) of the Disclosure Schedule, to the Knowledge of the Company:<\/p>\n<p>                              (A) the license and agreement are legal, valid,<br \/>\n            binding, enforceable, and in full force and effect;<\/p>\n<p>                              (B) the license and agreement will continue to be<br \/>\n            legal, valid, binding, enforceable, and in full force and effect on<br \/>\n            identical terms on the day immediately following the Closing;<\/p>\n<p>                              (C) no party to the agreement is in breach or<br \/>\n            default, and no event has occurred which with notice or lapse of<br \/>\n            time would constitute a breach or default or permit termination,<br \/>\n            modification, or acceleration thereunder;<\/p>\n<p>                              (D) no party to the agreement has repudiated any<br \/>\n            provision thereof;<\/p>\n<p>                                       12<br \/>\n   17<br \/>\n                              (F) the license is not subject to any outstanding<br \/>\n            injunction, judgment, order, decree, ruling, or charge; and<\/p>\n<p>                              (G) no action, suit, proceeding, hearing,<br \/>\n            investigation, charge, complaint, claim, or demand is pending or is<br \/>\n            threatened which challenges the legality, validity, or<br \/>\n            enforceability of the license or agreement.<\/p>\n<p>                        (iv) To the Knowledge of any of the Company and the<br \/>\n      directors and officers (and employees with responsibility for Intellectual<br \/>\n      Property matters) of the Company and its Subsidiaries, neither the Company<br \/>\n      nor any of its Subsidiaries will infringe, misappropriate, or otherwise<br \/>\n      violate any Intellectual Property rights of third parties as a result of<br \/>\n      the continued operation of its businesses as presently conducted and as<br \/>\n      presently proposed to be conducted.<\/p>\n<p>                        (v) To the Knowledge of the Company, the Year 2000<br \/>\n      Readiness Disclosure as currently published by the Company on its web site<br \/>\n      is accurate. A copy of this Year 2000 Readiness Disclosure is included in<br \/>\n      Section 3.1(m) of the Disclosure Schedule. The Company makes no other<br \/>\n      representation or warranty concerning any Year 2000 issue.<\/p>\n<p>                        (vi) Notwithstanding anything in this Agreement to the<br \/>\n      contrary, this subsection (m) and subsection (p) below are the sole,<br \/>\n      exclusive and entire representation and warranty of the Company concerning<br \/>\n      Intellectual Property or any infringement, misappropriation or violation<br \/>\n      of Intellectual Property. No other representation or warranty in this<br \/>\n      Agreement shall be construed as applying to Intellectual Property or any<br \/>\n      infringement, misappropriation or violation of Intellectual Property.<\/p>\n<p>                  (n) Tangible Assets. The Company and its Subsidiaries own or<br \/>\nlease all buildings, machinery, equipment, and other tangible assets necessary<br \/>\nfor the conduct of their business as presently conducted and as presently<br \/>\nproposed to be conducted.<\/p>\n<p>                  (o) Powers of Attorney. There are no outstanding powers of<br \/>\nattorney executed on behalf of any of the Company and its Subsidiaries outside<br \/>\nthe Ordinary Course of Business.<\/p>\n<p>                  (p) Litigation. Section 3.1(p) of the Disclosure Schedule sets<br \/>\nforth each instance in which any of the Company and its Subsidiaries (i) is<br \/>\nsubject to any outstanding injunction, judgment, order, decree, ruling, or<br \/>\ncharge or (ii) is a party or, to the Knowledge of any of the Company, the<br \/>\ndirectors and officers (and employees with responsibility for litigation<br \/>\nmatters) of the Company and its Subsidiaries, is threatened to be made a party<br \/>\nto any action, suit, proceeding, hearing, or investigation of, in, or before any<br \/>\ncourt or quasi-judicial or administrative agency of any federal, state, local,<br \/>\nor foreign jurisdiction or before any arbitrator. None of the actions, suits,<br \/>\nproceedings, hearings, and investigations set forth in Section 3.1(p) of the<br \/>\nDisclosure Schedule alone or in the aggregate could result in any adverse change<br \/>\nin the business, financial condition, operations, results of operations, or<br \/>\nfuture prospects of any of the Company and its Subsidiaries. None of the Company<br \/>\nthe directors and officers (and employees with responsibility for litigation<br \/>\nmatters) of the Company and its Subsidiaries has any reason to believe that any<br \/>\nsuch action, suit, proceeding, hearing, or investigation may be brought or<br \/>\nthreatened against any of the Company and its Subsidiaries.<\/p>\n<p>                                       13<br \/>\n   18<br \/>\n                  (q) Employees. To the Knowledge of the Company, the directors<br \/>\nand officers (and employees with responsibility for employment matters) of the<br \/>\nCompany and its Subsidiaries, no executive, key employee, or group of employees<br \/>\nhas any plans to terminate employment with any of the Company and its<br \/>\nSubsidiaries. None of the Company and its Subsidiaries is a party to or bound by<br \/>\nany collective bargaining agreement, nor has any of them experienced any<br \/>\nstrikes, grievances, claims of unfair labor practices, or other collective<br \/>\nbargaining disputes. None of the Company and its Subsidiaries has committed any<br \/>\nunfair labor practice. None of the directors and officers (and employees with<br \/>\nresponsibility for employment matters) of the Company and its Subsidiaries has<br \/>\nany Knowledge of any organizational effort presently being made or threatened by<br \/>\nor on behalf of any labor union with respect to employees of any of the Company<br \/>\nand its Subsidiaries.<\/p>\n<p>                  (r) Guaranties. None of the Company or its Subsidiaries is a<br \/>\nguarantor or otherwise is liable for any Liability or obligation (including<br \/>\nindebtedness) of any other Person.<\/p>\n<p>                  (s) Certain Business Relationships with the Company and Its<br \/>\nSubsidiaries. None of the Company&#8217;s Affiliates has been involved in any business<br \/>\narrangement or relationship with any of the Company or its Subsidiaries within<br \/>\nthe past twelve (12) months, and none of the Company&#8217;s Affiliates owns any<br \/>\nasset, tangible or intangible, which is used in the business of any of the<br \/>\nCompany or its Subsidiaries.<\/p>\n<p>                  (t) Capitalization, Etc.<\/p>\n<p>                        (i) The authorized capital stock of the Company consists<br \/>\n      of 50,000,000 shares of common stock, no par value, 16,000,000 shares of<br \/>\n      which have been issued and are outstanding, 4,000,000 shares of which have<br \/>\n      been reserved for issuance pursuant to the Company&#8217;s employee stock option<br \/>\n      plan and 1,000,000 additional shares of which are contemplated to be<br \/>\n      reserved for issuance pursuant to the Company&#8217;s employee stock option<br \/>\n      plan.<\/p>\n<p>                        (ii) All of the Company&#8217;s outstanding shares of Common<br \/>\n      Stock (i) have been duly authorized and validly issued, (ii) are fully<br \/>\n      paid and nonassessable, and (iii) have been issued in compliance with all<br \/>\n      applicable securities laws and other applicable legal requirements.<\/p>\n<p>                        (iii) Except as set forth in Section 3.1(t) of the<br \/>\n      Disclosure Schedule, there are no:<\/p>\n<p>                              (A) outstanding derivative securities;<\/p>\n<p>                              (B) contracts, agreements or other arrangements<br \/>\n            under which the Company is or may become obligated to sell or<br \/>\n            otherwise issue any shares of its capital stock or any derivative<br \/>\n            securities; or<\/p>\n<p>                              (C) conditions or circumstances that would<br \/>\n            directly or indirectly give rise to or provide a basis for the<br \/>\n            assertion of a claim by any Person to the effect that such Person is<br \/>\n            entitled to acquire or receive any shares of capital stock or other<br \/>\n            securities of the Company.<\/p>\n<p>                                       14<br \/>\n   19<br \/>\n                        (iv) The Company has never repurchased, redeemed or<br \/>\n      otherwise reacquired (and has not agreed, committed or offered (in writing<br \/>\n      or otherwise) to reacquire) any shares of its capital stock or any<br \/>\n      derivative securities.<\/p>\n<p>                  (u) Real Property; Leases. The Company does not own any real<br \/>\nproperty or any interest in real property, except for the leaseholds created<br \/>\nunder the real property leases identified in Section 3.1(u) of the Disclosure<br \/>\nSchedule. Section 3.1(u) of the Disclosure Schedule accurately and completely<br \/>\ndescribes the premises covered by said leases and the facilities located on such<br \/>\npremises. The Company enjoys peaceful and undisturbed possession of such<br \/>\npremises. All leases to which the Company is a party are valid, binding and<br \/>\nenforceable in accordance with their respective terms and are in full force and<br \/>\neffect; there are no material existing defaults by the Company or the other<br \/>\nparty thereunder, and no event of default has occurred which (whether with or<br \/>\nwithout notice, lapse of time or the happening or occurrence of any other event)<br \/>\nwould constitute a material default thereunder.<\/p>\n<p>                  (v) Environmental Matters. The Company is in compliance with<br \/>\nall applicable Environmental Health and Safety Requirements. The Company has not<br \/>\nreceived any notice or other communication (in writing or otherwise) that<br \/>\nalleges that the Company is not in compliance with any Environmental Health and<br \/>\nSafety Requirements and to the Company&#8217;s Knowledge there are no circumstances<br \/>\nthat are reasonably likely to prevent or interfere with the Company&#8217;s compliance<br \/>\nwith any Environmental Health and Safety Requirements in the future.<\/p>\n<p>                  (w) Sale of Products; Performance of Services. To the<br \/>\nKnowledge of the Company, no distributor, customer, end-user, consumer or other<br \/>\nPerson has ever asserted or threatened to assert any material claim against the<br \/>\nCompany (i) under or based upon any warranty provided by or on behalf of the<br \/>\nCompany, or (ii) relating to any product sold by the Company or any services<br \/>\nperformed by the Company. No event has occurred, and no condition or<br \/>\ncircumstance exists, that could (with or without notice or lapse of time)<br \/>\ndirectly or indirectly give rise to or serve as a basis for the assertion of any<br \/>\nsuch claim.<\/p>\n<p>                  (x) Full Disclosure.<\/p>\n<p>                        (i) None of the representations and warranties of the<br \/>\n      Company in this Agreement (including the Disclosure Schedule) contains or<br \/>\n      will contain as of the Closing Date any untrue statement of material fact<br \/>\n      or omits or will omit as of the Closing Date to state any fact necessary<br \/>\n      to make any of the representations, warranties or statements contained<br \/>\n      therein not misleading. To the extent such representations permit omission<br \/>\n      of items otherwise required to be discussed because they are not material<br \/>\n      or do not or would not have Adverse Consequences, such omissions in the<br \/>\n      aggregate will not as of the Closing Date and do not have Adverse<br \/>\n      Consequences.<\/p>\n<p>                        (ii) As of the date of this Agreement, the Company has<br \/>\n      provided the Buyer with full and complete access to all of the Company&#8217;s<br \/>\n      records and other documents and data requested by it.<\/p>\n<p>                        (iii) There is no fact within the Knowledge of the<br \/>\n      Company or its directors, officers or employees (other than publicly known<br \/>\n      facts or facts within the Knowledge of Buyer) that have Adverse<br \/>\n      Consequences.<\/p>\n<p>                                       15<br \/>\n   20<br \/>\n                        (iv) All of the written information set forth in the<br \/>\n      Disclosure Schedule, and all other information regarding the Company and<br \/>\n      its business, condition, assets, liabilities, operation, financial<br \/>\n      performance, net income and prospects that has been furnished to Buyer or<br \/>\n      any of its representatives by or on behalf of Company or any of the<br \/>\n      Company&#8217;s representatives, is accurate and complete in all material<br \/>\n      respects. The Company acknowledges and agrees that although Buyer may<br \/>\n      tender certain assistance to Company in the preparation of the Disclosure<br \/>\n      Schedule, the provision of such assistance shall not be deemed to<br \/>\n      constitute an admission by Buyer of the accuracy of the same or any basis<br \/>\n      for any modification of any covenant, representation or warranty of<br \/>\n      Company and Buyer contained in this Agreement.<\/p>\n<p>                  (y) Customers and Suppliers. As of the date hereof, no<br \/>\ncustomer that individually accounted for more than five percent (5%) of the<br \/>\nCompany&#8217;s gross revenues during the 12-month period preceding the date hereof<br \/>\nhas notified the Company that it will stop, or decrease the rate of, buying<br \/>\nservices or products of the Company, or has at any time on or after December 31,<br \/>\n1998 decreased materially its purchase of the products of the Company. As of the<br \/>\ndate hereof, no supplier of the Company has notified the Company that it will<br \/>\nstop, or decrease the rate of, supplying materials, products or services to the<br \/>\nCompany. The Company has not knowingly breached any contract with, or engaged in<br \/>\nany fraudulent conduct with respect to, any customer or supplier of the Company.<\/p>\n<p>                  (z) Inventories. The inventories of the Company that are<br \/>\nreflected in the Financial Statements consist of items that are usable or<br \/>\nsalable in the Ordinary Course of Business and do not include below-standard<br \/>\nquality, damaged, defective or obsolete items the value of which has not been<br \/>\nfully written down or with respect to which adequate reserves have not been<br \/>\nprovided, adjusted for operations and transactions through the Closing in<br \/>\naccordance with the past custom and practice of the Company.<\/p>\n<p>                  (aa) Financial Projections. The Company&#8217;s business plan as<br \/>\nheretofore provided to Buyer has been prepared by the Company based on the<br \/>\nCompany&#8217;s good faith estimates (based on reasonable investigation) of the<br \/>\nprojected financial performance of the Company following the Closing and certain<br \/>\nassumptions set forth therein, which assumptions the Company believes are<br \/>\nreasonable. The Company has concluded after reasonable investigation that the<br \/>\nassumptions and conclusions of the Company&#8217;s business plan constitute reasonable<br \/>\nestimates of the Company&#8217;s actual performance. However, such estimates and<br \/>\nprojections are not guaranteed or warranted.<\/p>\n<p>            3.2 Representations and Warranties of the Shareholder.<\/p>\n<p>            The Shareholder represents and warrants to the Buyer that the<br \/>\nstatements contained in this Section 3.2 are correct and complete as of the date<br \/>\nof this Agreement and will be correct and complete as of the Closing Date (as<br \/>\nthough made then and as though the Closing Date were substituted for the date of<br \/>\nthis Agreement throughout this Section 3.2) with respect to itself, except as<br \/>\nset forth in Annex II attached hereto.<\/p>\n<p>                  (a) Authorization of Transaction. The Shareholder has full<br \/>\npower and authority to execute and deliver this Agreement and the Investors<br \/>\nRights Agreement, and to perform its obligations hereunder and thereunder. Each<br \/>\nof the Transactional Agreements<\/p>\n<p>                                       16<br \/>\n   21<br \/>\nconstitutes the valid and legally binding obligation of the Shareholder,<br \/>\nenforceable in accordance with their respective terms and conditions. The<br \/>\nShareholder need not give any notice to, make any filing with, or obtain any<br \/>\nauthorization, consent, or approval of any government or governmental agency in<br \/>\norder to consummate the transactions contemplated by the Transactional<br \/>\nAgreements.<\/p>\n<p>                  (b) Noncontravention. Neither the execution and the delivery<br \/>\nof the Transactional Agreements, nor the consummation of the transactions<br \/>\ncontemplated hereby and thereby, will (i) violate any constitution, statute,<br \/>\nregulation, rule, injunction, judgment, order, decree, ruling, charge, or other<br \/>\nrestriction of any government, governmental agency, or court to which the<br \/>\nShareholder is subject or (ii) conflict with, result in a breach of, constitute<br \/>\na default under, result in the acceleration of, create in any party the right to<br \/>\naccelerate, terminate, modify, or cancel, or require any notice under any<br \/>\nagreement, contract, lease, license, instrument, or other arrangement to which<br \/>\nthe Shareholder is a party or by which it is bound or to which any of its assets<br \/>\nis subject.<\/p>\n<p>                  (c) Company Representations. To Shareholder&#8217;s Knowledge and<br \/>\nsubject to the matters described in the Disclosure Schedule, the representations<br \/>\nand warranties of the Company in Section 3.1 are true and correct in all<br \/>\nmaterial respects.<\/p>\n<p>            3.3 Representations and Warranties of the Buyer.<\/p>\n<p>            The Buyer represents and warrants to the Company and the Shareholder<br \/>\nthat the statements contained in this Section 3.3 are correct and complete as of<br \/>\nthe date of this Agreement and will be correct and complete as of the Closing<br \/>\nDate (as though made then and as though the Closing Date were substituted for<br \/>\nthe date of this Agreement throughout this Section 3.3), except as set forth in<br \/>\nAnnex III attached hereto.<\/p>\n<p>                  (a) Organization of the Buyer. The Buyer is a corporation duly<br \/>\norganized, validly existing, and in good standing under the laws of the<br \/>\njurisdiction of its incorporation.<\/p>\n<p>                  (b) Authorization of Transaction. The Buyer has full power and<br \/>\nauthority (including full corporate power and authority) to execute and deliver<br \/>\nthis Agreement and the Investors Rights Agreement and to perform its obligations<br \/>\nhereunder and thereunder. This Agreement and the Investors Rights Agreement<br \/>\nconstitute the valid and legally binding obligation of the Buyer, enforceable in<br \/>\naccordance with their respective terms and conditions. The Buyer need not give<br \/>\nany notice to, make any filing with, or obtain any authorization, consent or<br \/>\napproval of any government or governmental agency in order to consummate the<br \/>\ntransactions contemplated by this Agreement or the Investors Rights Agreement.<\/p>\n<p>                  (c) Noncontravention. Neither the execution and the delivery<br \/>\nof this Agreement or the Investors Rights Agreement, nor the consummation of the<br \/>\ntransactions contemplated hereby and thereby, will (i) violate any constitution,<br \/>\nstatute, regulation, rule, injunction, judgment, order, decree, ruling, charge,<br \/>\nor other restriction of any government, governmental agency, or court to which<br \/>\nthe Buyer is subject or any provision of its charter or bylaws or (ii) conflict<br \/>\nwith, result in a breach of, constitute a default under, result in the<br \/>\nacceleration of, create in any party the right to accelerate, terminate, modify,<br \/>\nor cancel, or require any notice under any agreement, contract, lease, license,<br \/>\ninstrument, or other arrangement to which the Buyer is a party or by which it is<br \/>\nbound or to which any of its assets is subject.<\/p>\n<p>                                       17<br \/>\n   22<br \/>\n                  (d) Brokers&#8217; Fees. The Buyer has no Liability or obligation to<br \/>\npay any fees or commissions to any broker, finder, or agent with respect to the<br \/>\ntransactions contemplated by this Agreement for which the Company could become<br \/>\nliable or obligated.<\/p>\n<p>                  (e) Investment. The Buyer (i) understands that the Company<br \/>\nShares have not been, and will not be, registered under the Securities Act, or<br \/>\nunder any state securities laws, and are being offered and sold in reliance upon<br \/>\nfederal and state exemptions for transactions not involving any public offering,<br \/>\n(ii) is a sophisticated investor with knowledge and experience in business and<br \/>\nfinancial matters, (iii) has received certain information concerning the Company<br \/>\nand has had the opportunity to obtain additional information as desired in order<br \/>\nto evaluate the merits and the risks inherent in holding the Company Shares,<br \/>\n(iv) is able to bear the economic risk and lack of liquidity inherent in holding<br \/>\nthe Company Shares, and (v) is an Accredited Investor who is acquiring the<br \/>\nCompany Shares for investment purposes, for its own account, not as a nominee or<br \/>\nagent and not with a view to the resale or distribution of any part thereof, and<br \/>\nit has no present intention of selling, granting any participation in, or<br \/>\notherwise distributing the same.<\/p>\n<p>      4. Pre-Closing Covenants.<\/p>\n<p>            The Parties agree as follows with respect to the period between the<br \/>\nexecution of this Agreement and the Closing.<\/p>\n<p>            4.1 General.<\/p>\n<p>            Each of the Parties will use its best efforts to take all action and<br \/>\nto do all things necessary, proper, or advisable in order to consummate and make<br \/>\neffective the transactions contemplated by this Agreement (including<br \/>\nsatisfaction, but not waiver, of the closing conditions set forth in Section 6<br \/>\nbelow).<\/p>\n<p>            4.2 Notices and Consents.<\/p>\n<p>            The Company and its Subsidiaries will give any notices to third<br \/>\nparties and use its best efforts to obtain any third party consents, that the<br \/>\nBuyer may reasonably request in connection with the matters referred to in<br \/>\nSection 3.1 above. Each of the Parties will give any notices to, make any<br \/>\nfilings with, and use its best efforts to obtain any authorizations, consents,<br \/>\nand approvals of governments and governmental agencies in connection with the<br \/>\nmatters referred to in Section 3.1(b), Section 3.2(a) and Section 3.3(b) above.<\/p>\n<p>            4.3 Operation of Business.<\/p>\n<p>            The Company and its Subsidiaries will not engage in any practice,<br \/>\ntake any action, or enter into any transaction outside the Ordinary Course of<br \/>\nBusiness. Without limiting the generality of the foregoing, the Company will not<br \/>\n(a) declare, set aside, or pay any dividend or make any distribution with<br \/>\nrespect to its capital stock or redeem, purchase, or otherwise acquire any of<br \/>\nits capital stock, or (b) otherwise engage in any practice, take any action, or<br \/>\nenter into any transaction of the sort described in Section 3.1(i) above.<\/p>\n<p>            4.4 Preservation of Business.<\/p>\n<p>            The Company and its Subsidiaries will keep their business and<br \/>\nproperties substantially intact, including its present operations, physical<br \/>\nfacilities, working conditions, and relationships with lessors, licensors,<br \/>\nsuppliers, customers, and employees.<\/p>\n<p>                                       18<br \/>\n   23<br \/>\n            4.5 Full Access.<\/p>\n<p>            The Company and its Subsidiaries will permit representatives of the<br \/>\nBuyer to have fall access at all reasonable times, and in a manner so as not to<br \/>\ninterfere with the normal business operations of the Company and its<br \/>\nSubsidiaries, to all premises, properties, personnel, books, records (including<br \/>\nTax records), contracts, and documents of or pertaining to each of the Company<br \/>\nand its Subsidiaries. Information disclosed by the Company and its Subsidiaries<br \/>\nto the Buyer or learned by the Buyer or its representatives from the access<br \/>\nprovided under this Section 4.5 shall be subject to Section 10.16.<\/p>\n<p>            4.6 Notice of Developments.<\/p>\n<p>            The Company and Shareholder will give prompt written notice to the<br \/>\nBuyer of any material adverse development causing a breach of any of the<br \/>\nrepresentations and warranties in Section 3.1 and Section 3.2 above. Each Party<br \/>\nwill give prompt written notice to the others of any material adverse<br \/>\ndevelopment causing a breach of any of his or its own representations and<br \/>\nwarranties in Section 3 above. No disclosure by any Party pursuant to this<br \/>\nSection 4.6, however, shall be deemed to amend or supplement Annex I, Annex II,<br \/>\nor Annex III or to prevent or cure any misrepresentation, breach of warranty, or<br \/>\nbreach of covenant.<\/p>\n<p>            4.7 Exclusivity.<\/p>\n<p>            None of the Company or Shareholder will (i) solicit, initiate, or<br \/>\nencourage the submission of any proposal or offer from any Person relating to<br \/>\nthe acquisition of control of a majority of any capital stock or other voting<br \/>\nsecurities, or any substantial portion of the assets, of the Company and its<br \/>\nSubsidiaries (including any acquisition structured as a merger, consolidation,<br \/>\nor share exchange) or (ii) participate in any discussions or negotiations<br \/>\nregarding, furnish any information with respect to, assist or participate in, or<br \/>\nfacilitate in any other manner any effort or attempt by any Person to do or seek<br \/>\nany of the foregoing. Shareholder will not vote the Shareholder Shares in favor<br \/>\nof any such acquisition structured as a merger, consolidation, or share<br \/>\nexchange. The Company and Shareholder will notify the Buyer immediately if any<br \/>\nPerson makes any proposal, offer, inquiry, or contact with respect to any of the<br \/>\nforegoing. This Section 4.7 shall terminate 60 days from the date of this<br \/>\nAgreement.<\/p>\n<p>      5. Post-Closing Covenants.<\/p>\n<p>            5.1 General.<\/p>\n<p>            In case at any time after the Closing any further action is<br \/>\nnecessary to carry out the purposes of this Agreement, each of the Parties will<br \/>\ntake such further action (including the execution and delivery of such further<br \/>\ninstruments and documents) as any other Party may reasonably request, all at the<br \/>\nsole cost and expense of the requesting Party (unless the requesting Party is<br \/>\nentitled to indemnification therefor under Section 7 below).<\/p>\n<p>            5.2 Consultation.<\/p>\n<p>            Buyer shall be entitled to reasonably consult with and advise<br \/>\nmanagement of the Company on significant business issues, including management&#8217;s<br \/>\nproposed annual operating plans, and management will meet with Buyer from time<br \/>\nto time at the Company&#8217;s facilities at Buyer&#8217;s expense at mutually agreeable<br \/>\ntimes for such consultation and advice and to review<\/p>\n<p>                                       19<br \/>\n   24<br \/>\nprogress in achieving said plans. The Company has no obligation to comply with<br \/>\nany advice or directions from Buyer. Information disclosed to Buyer pursuant to<br \/>\nthis Section 5.2 will be subject to Section 10.16. The rights set forth in<br \/>\nthis Section 5.2 shall terminate upon the earlier of the following: (i) if at<br \/>\nany time the Buyer ceases to own and control at least ten percent (10%) of the<br \/>\nissued and outstanding capital stock of the Company; (ii) the closing of any<br \/>\ninitial public offering of the capital stock of the Company pursuant to an<br \/>\neffective registration statement under the Securities Act; or (iii) the date the<br \/>\nCompany becomes subject to the reporting requirements of the Securities Exchange<br \/>\nAct.<\/p>\n<p>            5.3 Records.<\/p>\n<p>            Buyer may examine the books and records of the Company and inspect<br \/>\nits facilities and may request information at reasonable times and intervals<br \/>\nconcerning the general status of the Company&#8217;s financial condition and<br \/>\noperations, provided that access to confidential or proprietary information and<br \/>\nfacilities need not be provided. Information disclosed to or learned by the<br \/>\nBuyer pursuant to this Section 5.3 is subject to Section 10.16. The rights set<br \/>\nforth in this Section 5.3 shall terminate upon the earlier of the following: (i)<br \/>\nif at any time the Buyer ceases to own and control at least ten percent (10%)<br \/>\nof the issued and outstanding capital stock of the Company; (ii) the closing of<br \/>\nan initial public offering of the capital stock of the Company pursuant to an<br \/>\neffective registration statement under the Securities Act; or (iii) the date the<br \/>\nCompany becomes subject to the reporting requirements of the Securities Exchange<br \/>\nAct.<\/p>\n<p>            5.4 Observer Rights<\/p>\n<p>            If Buyer is not represented on the Company&#8217;s Board of Directors by<br \/>\nan affiliate of Buyer, the Company shall give a representative of Buyer copies<br \/>\nof all notices, minutes, consents and other material that the Company provides<br \/>\nto its directors and the Company shall invite a representative of Buyer to<br \/>\nattend all meetings of the Board of Directors in a non-voting observer capacity,<br \/>\nexcept that Buyer may be excluded from access to any material or meeting or<br \/>\nportion thereof if the Company believes, in good faith, that such exclusion is<br \/>\nreasonably necessary to preserve the attorney-client privilege, to protect<br \/>\nhighly confidential or proprietary information, to protect the interests of the<br \/>\nCompany or for other similar reasons. Upon reasonable notice and at a scheduled<br \/>\nmeeting of the Board of Directors or such other time, if any, as the Board of<br \/>\nDirectors may determine in its sole discretion, such representative may address,<br \/>\nsubject to reasonable limitations, the Board of Directors with respect to<br \/>\nBuyer&#8217;s concerns regarding significant business issues facing the Company.<br \/>\nInformation disclosed to or learned by the Buyer pursuant to this Section 5.4 is<br \/>\nsubject to Section 10.16. The rights set forth in this Section 5.4 shall<br \/>\nterminate upon the earlier of the following: (i) if at any time the Buyer ceases<br \/>\nto own and control at least ten percent (10%) of the issued and outstanding<br \/>\ncapital stock of the Company; (ii) the closing of an initial public offering of<br \/>\nthe capital stock of the Company pursuant to an effective registration statement<br \/>\nunder the Securities Act; or (iii) the date the Company becomes subject to the<br \/>\nreporting requirements of the Securities Exchange Act.<\/p>\n<p>            5.5 Legends.<\/p>\n<p>            To the extent applicable, each certificate or other document<br \/>\nevidencing any of the Company Shares shall be endorsed with the legend set forth<br \/>\nbelow, and Buyer covenants that, except for the transfer of shares pursuant to<br \/>\nRule 144, the removal of the legend set forth in this<\/p>\n<p>                                       20<br \/>\n   25<br \/>\nSection 5.5 pursuant to Rule 144, the transfer or the distributions to any<br \/>\nAffiliate, and to the extent such restrictions are waived by the Company, Buyer<br \/>\nshall not transfer the shares represented by any such certificate without<br \/>\ncomplying with the restrictions on transfer described in the legends endorsed on<br \/>\nsuch certificate:<\/p>\n<p>            &#8216;THE SECURITIES REPRESENTED BY TIES CERTIFICATE HAVE NOT BEEN<br \/>\n            REGISTERED OR QUALIFIED UNDER THE SECURITIES ACT OF 1933, AS<br \/>\n            AMENDED, OR THE SECURITIES LAWS OF ANY STATE, AND MAY BE OFFERED AND<br \/>\n            SOLD ONLY IF REGISTERED AND QUALIFIED PURSUANT TO THE RELEVANT<br \/>\n            PROVISIONS OF FEDERAL AND STATE SECURITIES LAWS OR IF THE COMPANY IS<br \/>\n            PROVIDED AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT<br \/>\n            REGISTRATION AND QUALIFICATION UNDER FEDERAL AND STATE SECURITIES<br \/>\n            LAWS IS NOT REQUIRED.&#8217;<\/p>\n<p>            5.6 Distribution and License Agreement.<\/p>\n<p>            The Company and Buyer shall enter into a reciprocal Distribution and<br \/>\nLicense Agreement in the form attached hereto as Exhibit &#8216;D&#8217;.<\/p>\n<p>            5.7 Further Actions. The Company shall, within 90 days after the<br \/>\nClosing Date, provide to Buyer evidence of the Company&#8217;s ownership of its<br \/>\nSubsidiaries to Buyer&#8217;s reasonable satisfaction.<\/p>\n<p>      6. Conditions to Obligation to Close.<\/p>\n<p>            6.1 Conditions to Obligation of the Buyer.<\/p>\n<p>            The obligation of the Buyer to consummate the transactions to be<br \/>\nperformed by it in connection with the Closing is subject to satisfaction of the<br \/>\nfollowing conditions:<\/p>\n<p>                  (a) each of the representations and warranties set forth in<br \/>\nSections 3.1 and 3.2 above that is qualified by materiality shall be true and<br \/>\ncorrect at and as of the Closing Date, and each of the representations and<br \/>\nwarranties set forth in Sections 3.1 and 3.2 above that is not so qualified<br \/>\nshall be true and correct in all material respects at and as of the Closing<br \/>\nDate;<\/p>\n<p>                  (b) the Company and Shareholder shall have performed and<br \/>\ncomplied with all of their covenants hereunder in all material respects through<br \/>\nthe Closing;<\/p>\n<p>                  (c) the Company and its Subsidiaries shall have procured all<br \/>\nof the third party consents specified in Section 3.1 above;<\/p>\n<p>                  (d) no action, suit, or proceeding shall be pending or<br \/>\nthreatened before any court or quasi-judicial or administrative agency of any<br \/>\nfederal, state, local, or foreign jurisdiction or before any arbitrator wherein<br \/>\nan unfavorable injunction, judgment, order, decree, ruling, or charge would (i)<br \/>\nprevent consummation of any of the transactions contemplated by this Agreement,<br \/>\n(ii) cause any of the transactions contemplated by this Agreement to be<br \/>\nrescinded following consummation, (iii) affect adversely the right of the Buyer<br \/>\nto own the Company Shares, or (iv) affect adversely the right of any of the<br \/>\nCompany and its Subsidiaries to own its assets and to operate its businesses<br \/>\n(and no such injunction, judgment, order, decree, ruling, or charge shall be in<br \/>\neffect);<\/p>\n<p>                                       21<br \/>\n   26<br \/>\n                  (e) the Company Shares that are being purchased by the Buyer,<br \/>\nwhen issued, sold and delivered in accordance with the terms of this Agreement<br \/>\nfor the consideration expressed herein, will be duly and validly issued,<br \/>\nnonassessable and free from rights of first refusal or other restrictions.<\/p>\n<p>                  (f) the Company shall have delivered to the Buyer a<br \/>\ncertificate to the effect that the conditions specified above in Section<br \/>\n6.1(a)-(e) are satisfied in all respects;<\/p>\n<p>                  (g) all applicable waiting periods (and any extensions<br \/>\nthereof) under the Hart-Scott-Rodino Act shall have expired or otherwise been<br \/>\nterminated and the Parties, including the Company&#8217;s Subsidiaries, shall have<br \/>\nreceived all other authorizations, consents, and approvals of governments and<br \/>\ngovernmental agencies referred to in Section 3.1(b), Section 3.2(a), and Section<br \/>\n3.3(b) above;<\/p>\n<p>                  (h) the Buyer shall have received from counsel to the Company<br \/>\nan opinion in form and substance as set forth in Exhibit &#8216;B&#8217; attached hereto,<br \/>\naddressed to the Buyer, and dated as of the Closing Date;<\/p>\n<p>                  (i) the Buyer shall have obtained on terms and conditions<br \/>\nsatisfactory to it all of the financing it needs in order to consummate the<br \/>\ntransactions contemplated hereby;<\/p>\n<p>                  (j) the Company and Shareholder shall have entered into and<br \/>\ndelivered an Investors Rights Agreement substantially in the form attached as<br \/>\nExhibit &#8216;C&#8217;;<\/p>\n<p>                  (k) the Company and the Buyer shall have entered into and<br \/>\ndelivered the Distribution and License Agreement substantially in the form<br \/>\nattached as Exhibit &#8216;D&#8217;; and<\/p>\n<p>                  (l) all actions to be taken by the Company and Shareholder in<br \/>\nconnection with consummation of the transactions contemplated hereby and all<br \/>\ncertificates, opinions, instruments, and other documents required to effect the<br \/>\ntransactions contemplated hereby will be satisfactory in form and substance to<br \/>\nthe Buyer.<\/p>\n<p>            The Buyer may waive any condition specified in this Section 6.1.<\/p>\n<p>            6.2 Conditions to Obligation of the Company and Shareholder.<\/p>\n<p>            The obligation of the Company and Shareholder to consummate the<br \/>\ntransactions to be performed by them in connection with the Closing is subject<br \/>\nto satisfaction of the following conditions:<\/p>\n<p>                  (a) the representations and warranties set forth in Section<br \/>\n3.3 above shall be true and correct in all material respects at and as of the<br \/>\nClosing Date;<\/p>\n<p>                  (b) the Buyer shall have performed and complied with all of<br \/>\nits covenants hereunder in all material respects through the Closing;<\/p>\n<p>                  (c) no action, suit, or proceeding shall be pending wherein<br \/>\nan unfavorable injunction, judgment, order, decree, ruling, or charge would (i)<br \/>\nprevent consummation of any of the transactions contemplated by this Agreement<br \/>\nor (ii) cause any of the transactions contemplated by this Agreement to be<br \/>\nrescinded following consummation (and no such injunction, judgment, order,<br \/>\ndecree, ruling, or charge shall be in effect);<\/p>\n<p>                                       22<br \/>\n   27<br \/>\n                  (d) the Buyer shall have delivered to the Company a<br \/>\ncertificate to the effect that each of the conditions specified above in Section<br \/>\n6.2(a)-(c) is satisfied in all respects;<\/p>\n<p>                  (e) all applicable waiting periods (and any extensions<br \/>\nthereof) under the Hart-Scott-Rodino Act shall have expired or otherwise been<br \/>\nterminated and the Parties, including the Company&#8217;s Subsidiaries, shall have<br \/>\nreceived all other authorizations, consents, and approvals of governments and<br \/>\ngovernmental agencies referred to in Section 3.1(b), Section 3.2(a), and Section<br \/>\n3.3(b) above; and<\/p>\n<p>                  (f) the Company and the Buyer shall have entered into and<br \/>\ndelivered the Distribution and License Agreement substantially in the form<br \/>\nattached as Exhibit &#8216;D&#8217;;<\/p>\n<p>                  (g) all actions to be taken by the Buyer in connection with<br \/>\nconsummation of the transactions contemplated hereby and all certificates,<br \/>\nopinions, instruments, and other documents required to effect the transactions<br \/>\ncontemplated hereby will be reasonably satisfactory in form and substance to the<br \/>\nCompany and Shareholder.<\/p>\n<p>            The Company and Shareholder may waive any condition specified in<br \/>\nthis Section 6.2.<\/p>\n<p>      7. Remedies for Breaches of this Agreement.<\/p>\n<p>            7.1 Survival of Representations and Warranties.<\/p>\n<p>      All of the representations and warranties of the Parties contained in<br \/>\nSections 3.1(a) through (e) and 3.3 of this Agreement shall survive the Closing<br \/>\nhereunder (even if the damaged Party knew or had reason to know of any<br \/>\nmisrepresentation or breach of warranty or covenant at the time of Closing) and<br \/>\ncontinue in full force and effect forever thereafter. The representations and<br \/>\nwarranties of the Company contained in Section 3.1(1) (with respect to taxes)<br \/>\nshall survive the Closing hereunder and shall continue in full force and effect<br \/>\nthereafter, as they relate to any taxable year of the Company, until sixty (60)<br \/>\ndays after the expiration of the statute of limitations applicable to the making<br \/>\nof adjustments or assessments by any taxing authority as the same may be<br \/>\nextended by the Company. All of the other representations, warranties and<br \/>\ncovenants of the Parties contained in this Agreement shall survive the Closing<br \/>\nhereunder (even if the damaged Party knew or had reason to know of any<br \/>\nmisrepresentation or breach of warranty or covenant at the time of Closing) and<br \/>\ncontinue in full force and effect thereafter until two years from the Closing<br \/>\nDate. Except as otherwise provided in the first sentence of this Section 7.1,<br \/>\nafter said survival period, all representations and warranties shall terminate,<br \/>\nand no party shall have any Liability or obligation with respect to any<br \/>\nrepresentation or warranty under this Agreement, provided that once notice of<br \/>\nany claim has been timely given, additional related claims arising out of<br \/>\nsubstantially the same circumstances may be made at any time prior to the<br \/>\nresolution of such claim (by means of a final, non-appealable judgment of a<br \/>\ncourt of competent jurisdiction, a binding arbitration decision or a settlement<br \/>\napproved by the parties involved) even if such resolution occurs after the<br \/>\nexpiration or termination date, if any, prescribed for such representation or<br \/>\nwarranty in this Section 7.1.<\/p>\n<p>            7.2 Indemnification Provisions for Benefit of the Buyer.<\/p>\n<p>                  (a) In the event that (i) the Company breaches any of its<br \/>\nrepresentations, warranties, and covenants contained herein, then the Company<br \/>\nagrees to indemnify the Buyer from and against any Adverse Consequences the<br \/>\nBuyer may suffer through and after the date of the claim<\/p>\n<p>                                       23<br \/>\n   28<br \/>\nfor indemnification (including any Adverse Consequences the Buyer may suffer<br \/>\nafter the end of any applicable survival period) resulting from, arising out of<br \/>\nor caused by such breach by the Company of any of its representations,<br \/>\nwarranties or covenants made herein, or (ii) the Shareholder breaches any of its<br \/>\nrepresentations, warranties, and covenants contained herein, then the<br \/>\nShareholder agrees to indemnify the Buyer from and against any Adverse<br \/>\nConsequences the Buyer may suffer through and after the date of the claim for<br \/>\nindemnification (including any Adverse Consequences the Buyer may suffer after<br \/>\nthe end of any applicable survival period) resulting from, arising out of or<br \/>\ncaused by such breach by the Shareholder of any of its representations,<br \/>\nwarranties or covenants made herein.<\/p>\n<p>                  (b) In the event that a third party asserts any claim against<br \/>\nthe Company alleging that the Company has violated the Intellectual Property<br \/>\nrights of such third party based on acts that occurred during the two year<br \/>\nperiod following the Closing Date, then the Company agrees to indemnify the<br \/>\nBuyer from and against any Adverse Consequences the Buyer may suffer through and<br \/>\nafter the date of the claim for indemnification (including any Adverse<br \/>\nConsequences the Buyer may suffer after the end of any applicable survival<br \/>\nperiod) resulting from, arising out of or caused by such third party claim.<\/p>\n<p>                  (c) Notwithstanding the foregoing provisions of this Section<br \/>\n7.2, no indemnification shall be payable by the Company or the Shareholder with<br \/>\nrespect to any claim for breach of any representation, warranty or covenant made<br \/>\nherein or claim by any third party until the total of such claims for<br \/>\nindemnification shall exceed US$75,000 (the &#8216;Deductible&#8217;), in which event the<br \/>\nBuyer shall be entitled to recover the amount of such claims in excess of the<br \/>\nDeductible; and provided, further, that the aggregate liability of either the<br \/>\nCompany or the Shareholder for indemnification payable hereunder shall not<br \/>\nexceed the amount of (i) the Purchase Price, plus (ii) reasonable attorneys&#8217;<br \/>\nfees and expenses incurred by the Buyer in seeking indemnification under this<br \/>\nSection 7.<\/p>\n<p>            7.3 Indemnification Provisions for Benefit of the Company and<br \/>\nShareholder.<\/p>\n<p>            In the event the Buyer breaches any of its representations,<br \/>\nwarranties, and covenants contained herein, then the Buyer agrees to indemnify<br \/>\neach of the Company and Shareholder from and against the entirety of any Adverse<br \/>\nConsequences they may suffer through and after the date of the claim for<br \/>\nindemnification (including any Adverse Consequences they may suffer after the<br \/>\nend of any applicable survival period) resulting from, arising out of or caused<br \/>\nby the breach; provided, however, that no indemnification shall be payable by<br \/>\nthe Buyer with respect to any claim for breach of any representation, warranty<br \/>\nor covenant made herein until the total of such claims for indemnification shall<br \/>\nexceed US$75,000, in which event the Company and the Shareholder, as the case<br \/>\nmay be, shall be entitled to recover the amount of such claims in excess of the<br \/>\nDeductible; and provided, further, that the aggregate liability of the Buyer for<br \/>\nindemnification payable hereunder shall not exceed $1 million, except for any<br \/>\nbreach of Buyer&#8217;s obligation to pay the Purchase Price under Section 2.<\/p>\n<p>            7.4 Matters Involving Third Parties.<\/p>\n<p>                  (a) If any third party shall notify any Party (the<br \/>\n&#8216;Indemnified Party&#8217;) with respect to any matter (a &#8216;Third Party Claim&#8217;) which<br \/>\nmay give rise to a claim for indemnification against any other Party (the<br \/>\n&#8216;Indemnifying Party&#8217;) under this Section 7, then the<\/p>\n<p>                                       24<br \/>\n   29<br \/>\nIndemnified Party shall promptly notify each Indemnifying Party thereof in<br \/>\nwriting; provided, however, that no delay on the part of the Indemnified Party<br \/>\nin notifying any Indemnifying Party shall relieve the Indemnifying Party from<br \/>\nany obligation hereunder unless (and then solely to the extent) the Indemnifying<br \/>\nParty thereby is prejudiced.<\/p>\n<p>                  (b) Any Indemnifying Party will have the right to defend the<br \/>\nIndemnified Party against the Third Party Claim with counsel of its choice<br \/>\nreasonably satisfactory to the Indemnified Party so long as (i) the Indemnifying<br \/>\nParty notifies the Indemnified Party in writing within 15 days after the<br \/>\nIndemnified Party has given notice of the Third Party Claim that the<br \/>\nIndemnifying Party will indemnify the Indemnified Party from and against the<br \/>\nentirety of any Adverse Consequences the Indemnified Party may suffer resulting<br \/>\nfrom, arising out of, or caused by the Third Party Claim, (ii) the Indemnifying<br \/>\nParty provides the Indemnified Party with evidence reasonably acceptable to the<br \/>\nIndemnified Party that the Indemnifying Party will have the financial resources<br \/>\nto defend against the Third Party Claim and fulfill its indemnification<br \/>\nobligations hereunder, (iii) the Third Party Claim involves only money damages<br \/>\nand does not seek an injunction or other equitable relief, (iv) settlement of,<br \/>\nor an adverse judgment with respect to, the Third Party Claim is not, in the<br \/>\ngood faith judgment of the Indemnified Party, likely to establish a precedential<br \/>\ncustom or practice materially adverse to the continuing business interests of<br \/>\nthe Indemnified Party, and (v) the Indemnifying Party conducts the defense of<br \/>\nthe Third Party Claim actively and diligently.<\/p>\n<p>                  (c) So long as the Indemnifying Party is conducting the<br \/>\ndefense of the Third Party Claim in accordance with Section 7.4(b) above, (A)<br \/>\nthe Indemnified Party may retain separate co-counsel at its sole cost and<br \/>\nexpense and participate in the defense of the Third Party Claim, (B) the<br \/>\nIndemnified Party will not consent to the entry of any judgment or enter into<br \/>\nany settlement with respect to the Third Party Claim without the prior written<br \/>\nconsent of the Indemnifying Party (not to be withheld unreasonably), and (C) the<br \/>\nIndemnifying Party will not consent to the entry of any judgment or enter into<br \/>\nany settlement with respect to the Third Party Claim without the prior written<br \/>\nconsent of the Indemnified Party (not to be withheld unreasonably).<\/p>\n<p>                  (d) In the event any of the conditions in Section 7.4(b) above<br \/>\nis or becomes unsatisfied, however, (i) the Indemnified Party may defend<br \/>\nagainst, and consent to the entry of any judgment or enter into any settlement<br \/>\nwith respect to, the Third Party Claim in any manner it reasonably may deem<br \/>\nappropriate (and the Indemnified Party need not consult with, or obtain any<br \/>\nconsent from, any Indemnifying Party in connection therewith), (ii) the<br \/>\nIndemnifying Parties will reimburse the Indemnified Party promptly and<br \/>\nperiodically for the costs of defending against the Third Party Claim (including<br \/>\nreasonable attorneys&#8217; fees and expenses), and (iii) the Indemnifying Parties<br \/>\nwill remain responsible for any Adverse Consequences the Indemnified Party may<br \/>\nsuffer resulting from, arising out of or caused by the Third Party Claim to the<br \/>\nfullest extent provided in this Section 7.<\/p>\n<p>            7.5 Determination of Adverse Consequences.<\/p>\n<p>            The Parties shall take into account the time cost of money (using<br \/>\nthe Applicable Rate as the discount rate) in determining Adverse Consequences<br \/>\nfor purposes of this Section 7.<\/p>\n<p>                                       25<br \/>\n   30<br \/>\n            7.6 Recoupment Against Purchase Price.<\/p>\n<p>                  (a) The Buyer shall have the option of recouping all or any<br \/>\npart of any Adverse Consequences it may suffer (in lieu of seeking any<br \/>\nindemnification to which it is entitled under this Section 7) at any time or<br \/>\nfrom time to time by providing the Company with at least thirty (30) days&#8217;<br \/>\nnotice (a &#8216;Reduction Notice&#8217;) of Buyer&#8217;s intent to reduce the amount of Purchase<br \/>\nPrice due to the Company in the Second Distribution and the Final Distribution,<br \/>\ntogether with all documentation and information reasonably necessary to<br \/>\nsubstantiate Buyer&#8217;s Adverse Consequences and Buyer&#8217;s claim for satisfaction of<br \/>\nsuch Adverse Consequences.<\/p>\n<p>                  (b) On or prior to the thirtieth (30th) day following the<br \/>\ndelivery of a Reduction Notice, the Company may deliver to Buyer a written<br \/>\nstatement (a &#8216;Reduction Disputing Notice&#8217;) setting forth with reasonable<br \/>\nspecificity any disagreement with any of the amounts contained in the Reduction<br \/>\nNotice which could affect the necessity or amount of any reduction of the<br \/>\nportion of the Purchase Price due to the Company in the Second Distribution and<br \/>\nthe Final Distribution. The sole basis for any disagreement with a Reduction<br \/>\nNotice shall be either (i) that the Adverse Consequences claimed by Buyer do not<br \/>\ngive rise to a claim for indemnification under this Section 7 or (ii) that there<br \/>\nhas been an arithmetical error in adding the Adverse Consequences. If the<br \/>\nCompany does not submit a Reduction Disputing Notice on or prior to such<br \/>\nthirtieth (30th) day, then the portion of the Purchase Price due to the Company<br \/>\nin the Second Distribution and the Final Distribution shall be deemed to have<br \/>\nbeen reduced for purposes of this Agreement in the amount set forth in the<br \/>\nReduction Notice. If the Company does submit a Reduction Disputing Notice on or<br \/>\nprior to such thirtieth (30th) day, any amounts contained in such Reduction<br \/>\nNotice which are not disputed by the Reduction Disputing Notice shall be deemed<br \/>\nto have been finally determined for purposes of this Agreement.<\/p>\n<p>                  (c) For a period of sixty (60) days, Buyer and the Company<br \/>\nshall attempt to resolve in good faith any dispute or disagreement between a<br \/>\nReduction Notice and a Reduction Disputing Notice. Amounts contained on a<br \/>\nReduction Notice and resolved by such attempts shall be deemed to have been<br \/>\nfinally determined for purposes of this Agreement. After such sixty (60) day<br \/>\nperiod, either party may commence legal proceedings to resolve any such dispute.<\/p>\n<p>            7.7 Exclusive Remedy for Non-Intentional Violations.<\/p>\n<p>            The foregoing indemnification provisions shall be the sole and<br \/>\nexclusive remedy for claims relating to any breach of the representations,<br \/>\nwarranties and covenants made herein by the respective Parties with respect to<br \/>\nthe transactions contemplated herein. Notwithstanding the foregoing limitation,<br \/>\nin the case of any intentional or knowing breach of the representations,<br \/>\nwarranties or covenants made by the respective Parties herein or intentionally<br \/>\nfraudulent or tortious conduct (&#8216;Intentional Violations&#8217;), the indemnification<br \/>\nprovisions herein are in addition to, and not in derogation of, any statutory,<br \/>\nequitable or common law remedy (including without limitation any such remedy<br \/>\narising under Environmental, Health and Safety Requirements) any Party may have<br \/>\nwith respect to the Buyer, the Company, its Subsidiaries or the transactions<br \/>\ncontemplated by this Agreement.<\/p>\n<p>                                       26<br \/>\n   31<br \/>\n      8. Tax Matters.<\/p>\n<p>            8.1 Certain Taxes.<\/p>\n<p>            All transfer, documentary, sales, use, stamp, registration and other<br \/>\nsuch Taxes and fees (including any penalties and interest) incurred in<br \/>\nconnection with the sale of the Company Shares under this Agreement (including<br \/>\nany gains tax or transfer tax imposed in state or subdivision), shall be paid by<br \/>\nthe Company when due, and the Company will, at its own expense, file all<br \/>\nnecessary Tax Returns and other documentation with respect to all such transfer,<br \/>\ndocumentary, sales, use, stamp, registration and other Taxes and fees, and, if<br \/>\nrequired by applicable law, Buyer will, and will cause its affiliates to, join<br \/>\nin the execution of any such Tax Returns and other documentation.<\/p>\n<p>      9. Termination.<\/p>\n<p>            9.1 Termination of Agreement.<\/p>\n<p>            Certain of the Parties may terminate this Agreement as provided<br \/>\nbelow:<\/p>\n<p>                  (a) the Buyer and the Company may terminate this Agreement by<br \/>\nmutual written consent at any time prior to the Closing;<\/p>\n<p>                  (b) the Buyer may terminate this Agreement by giving written<br \/>\nnotice to the Company prior to the Closing if the Buyer is not satisfied with<br \/>\nthe results of its continuing business, legal, environmental, and accounting due<br \/>\ndiligence regarding the Company and its Subsidiaries;<\/p>\n<p>                  (c) the Buyer may terminate this Agreement by giving written<br \/>\nnotice to the Company at any time prior to the Closing (i) in the event any of<br \/>\nthe Company or the Shareholder has breached any material representation,<br \/>\nwarranty, or covenant contained in this Agreement in any material respect, the<br \/>\nBuyer has notified the Company or the Shareholder of the breach, and the breach<br \/>\nhas continued without cure for a period of 30 days after the notice of breach or<br \/>\n(ii) if the Closing shall not have occurred on or before August 31, 1999, by<br \/>\nreason of the failure of any condition precedent under Section 6.1 hereof<br \/>\n(unless the failure results primarily from the Buyer itself breaching any<br \/>\nrepresentation, warranty, or covenant contained in this Agreement); and<\/p>\n<p>                  (d) the Company may terminate this Agreement by giving written<br \/>\nnotice to the Buyer at any time prior to the Closing (i) in the event the Buyer<br \/>\nhas breached any material representation, warranty, or covenant contained in<br \/>\nthis Agreement in any material respect, the Company has notified the Buyer of<br \/>\nthe breach, and the breach has continued without cure for a period of 30 days<br \/>\nafter the notice of breach or (ii) if the Closing shall not have occurred on or<br \/>\nbefore August 31, 1999, by reason of the failure of any condition precedent<br \/>\nunder Section 6.2 hereof (unless the failure results primarily from any of the<br \/>\nCompany or the Shareholder themselves breaching any representation, warranty, or<br \/>\ncovenant contained in this Agreement).<\/p>\n<p>            9.2 Effect of Termination.<\/p>\n<p>            If any Party terminates this Agreement pursuant to Section 9.1<br \/>\nabove, all rights and obligations of the Parties hereunder shall terminate<br \/>\nwithout any Liability of any Party to any other Party (except for any Liability<br \/>\nof any Party then in breach).<\/p>\n<p>                                       27<br \/>\n   32<br \/>\n      10. Miscellaneous.<\/p>\n<p>            10.1 Press Releases and Public Announcements.<\/p>\n<p>            No Party shall issue any press release or make any public<br \/>\nannouncement relating to the subject matter of this Agreement without the prior<br \/>\nwritten approval of the Buyer and the Company; provided, however, that any Party<br \/>\nmay make any public disclosure it believes in good faith is required by<br \/>\napplicable law or any listing or trading agreement concerning its<br \/>\npublicly-traded securities (in which case the disclosing Party will use its<br \/>\nreasonable best efforts to advise the other Parties prior to making the<br \/>\ndisclosure).<\/p>\n<p>            10.2 No Third-Party Beneficiaries.<\/p>\n<p>            This Agreement shall not confer any rights or remedies upon any<br \/>\nPerson other than the Parties and their respective successors and permitted<br \/>\nassigns.<\/p>\n<p>            10.3 Entire Agreement.<\/p>\n<p>            This Agreement (including the documents referred to herein)<br \/>\nconstitutes the entire agreement among the Parties and supersedes any prior<br \/>\nunderstandings, agreements, or representations by or among the Parties, written<br \/>\nor oral, to the extent they related in any way to the subject matter hereof.<\/p>\n<p>            10.4 Succession and Assignment.<\/p>\n<p>            This Agreement shall be binding upon and inure to the benefit of the<br \/>\nParties named herein and their respective successors and permitted assigns. No<br \/>\nParty may assign either this Agreement or any of his or its rights, interests,<br \/>\nor obligations hereunder without the prior written approval of the Buyer, the<br \/>\nCompany and the Shareholder; provided, however, that the Buyer may (a) assign<br \/>\nany or all of its rights and interests hereunder to one or more of its<br \/>\nAffiliates, (b) designate one or more of its Affiliates to perform its<br \/>\nobligations hereunder (in any or all of which cases the Buyer nonetheless shall<br \/>\nremain responsible for the performance of all of its obligations hereunder), and<br \/>\n(c) assign any or all of its rights and interests hereunder in connection with<br \/>\nany merger or sale of all or substantially all of its assets or capital stock.<br \/>\nAfter the Closing and without any prior approval of any other Party, this<br \/>\nAgreement may be assigned by any Party to any successor to its business or to<br \/>\nany purchaser or transferee of substantially all of its assets; provided,<br \/>\nhowever, that such assignment shall not be deemed to relieve the assigning Party<br \/>\nof any of its obligations hereunder.<\/p>\n<p>            10.5 Counterparts.<\/p>\n<p>            This Agreement may be executed in one or more counterparts, each of<br \/>\nwhich shall be deemed an original but all of which together will constitute one<br \/>\nand the same instrument.<\/p>\n<p>            10.6 Headings.<\/p>\n<p>            The Section headings contained in this Agreement are inserted for<br \/>\nconvenience only and shall not affect in any way the meaning or interpretation<br \/>\nof this Agreement.<\/p>\n<p>            10.7 Notices.<\/p>\n<p>            All notices, requests, demands, claims, and other communications<br \/>\nhereunder will be in writing. Any notice, request, demand, claim, or other<br \/>\ncommunication hereunder shall be deemed<\/p>\n<p>                                       28<br \/>\n   33<br \/>\nduly given if (and then two business days after) it is sent by registered or<br \/>\ncertified mail, return receipt requested, postage prepaid, and addressed to the<br \/>\nintended recipient as set forth below:<\/p>\n<p>             If to the Company:                   Copy to:<br \/>\n             Caldera Systems, Inc.                Parsons, Behle &amp; Latimer<br \/>\n             240 West Center Street               1 South Main Street<br \/>\n             Orem, Utah 84057                     Suite 1800<br \/>\n             Attn: Ransom Love, President &amp; Salt Lake City, Utah 84145<br \/>\n                   Chief Executive Officer        Attn: Brent Christensen, Esq.<\/p>\n<p>             If to the Shareholder:               Copy to:<br \/>\n             The Canopy Group, Inc.               Parsons, Behle &amp; Latimer<br \/>\n             240 West Center Street               1 South Main Street<br \/>\n             Orem, Utah 84057                     Suite 1800<br \/>\n             Attn: Ray Noorda and Ralph Yarro     Salt Lake City, Utah 84145<br \/>\n                                                  Attn: Brent Christensen, Esq.<\/p>\n<p>             If to the Buyer:                     Copy to:<br \/>\n             MTI Technology Corporation           Morrison &amp; Foerster LLP<br \/>\n             4905 East La Palma Avenue            19900 MacArthur Boulevard<br \/>\n             Anaheim, California 92807            Irvine, California 92612<br \/>\n             Attn: Chief Financial Officer        Attn: Tamara Powell Tate, Esq.<\/p>\n<p>Any Party may send any notice, request, demand, claim, or other communication<br \/>\nhereunder to the intended recipient at the address set forth above using any<br \/>\nother means (including personal delivery, expedited courier, messenger service,<br \/>\ntelecopy, telex, ordinary mail, or electronic mail), but no such notice,<br \/>\nrequest, demand, claim, or other communication shall be deemed to have been duly<br \/>\ngiven unless and until it actually is received by the intended recipient. Any<br \/>\nParty may change the address to which notices, requests, demands, claims, and<br \/>\nother communications hereunder are to be delivered by giving the other Parties<br \/>\nnotice in the manner herein set forth.<\/p>\n<p>            10.8 Governing Law.<\/p>\n<p>            This agreement is to be construed in accordance with and governed by<br \/>\nthe internal laws of the State of California (as permitted by Section 1646.5 of<br \/>\nthe California Civil Code or any similar successor provision) without giving<br \/>\neffect to any choice of law rule that would cause the application of the laws of<br \/>\nany jurisdiction other than the internal laws of the State of California to the<br \/>\nrights and duties of the parties.<\/p>\n<p>            10.9 Amendments and Waivers.<\/p>\n<p>            No amendment of any provision of this Agreement shall be valid<br \/>\nunless the same shall be in writing and signed by the Buyer, the company and the<br \/>\nShareholder. No waiver by any Party of any default, misrepresentation, or breach<br \/>\nof warranty or covenant hereunder, whether intentional or not, shall be deemed<br \/>\nto extend to any prior or subsequent default, misrepresentation, or breach of<br \/>\nwarranty or covenant hereunder or affect in any way any rights arising by virtue<br \/>\nof any prior or subsequent such occurrence.<\/p>\n<p>                                       29<br \/>\n   34<br \/>\n            10.10 Severability.<\/p>\n<p>            Any term or provision of this Agreement that is invalid or<br \/>\nunenforceable in any situation in any jurisdiction shall not affect the validity<br \/>\nor enforceability of the remaining terms and provisions hereof or the validity<br \/>\nor enforceability of the offending term or provision in any other situation or<br \/>\nin any other jurisdiction.<\/p>\n<p>            10.11 Expenses.<\/p>\n<p>            Each of the Parties will bear its own costs and expenses (including<br \/>\nlegal fees and expenses) incurred in connection with this Agreement and the<br \/>\ntransactions contemplated hereby.<\/p>\n<p>            10.12 Construction.<\/p>\n<p>            The Parties have participated jointly in the negotiation and<br \/>\ndrafting of this Agreement. In the event an ambiguity or question of intent or<br \/>\ninterpretation arises, this Agreement shall be construed as if drafted jointly<br \/>\nby the Parties and no presumption or burden of proof shall arise favoring or<br \/>\ndisfavoring any Party by virtue of the authorship of any of the provisions of<br \/>\nthis Agreement. Any reference to any federal, state, local, or foreign statute<br \/>\nor law shall be deemed also to refer to all rules and regulations promulgated<br \/>\nthereunder, unless the context requires otherwise. The word &#8216;including&#8217; shall<br \/>\nmean including without limitation. The Parties intend that each representation,<br \/>\nwarranty, and covenant contained herein shall have independent significance. If<br \/>\nany Party has breached any representation, warranty, or covenant contained<br \/>\nherein in any respect, the fact that there exists another representation,<br \/>\nwarranty, or covenant relating to the same subject matter (regardless of the<br \/>\nrelative levels of specificity) which the Party has not breached shall not<br \/>\ndetract from or mitigate the fact that the Party is in breach of the first<br \/>\nrepresentation, warranty, or covenant.<\/p>\n<p>            10.13 Incorporation of Exhibits, Annexes, and Schedules.<\/p>\n<p>            The Exhibits, Annexes, and Schedules identified in this Agreement<br \/>\nare incorporated herein by reference and made a part hereof. However, the<br \/>\nDistribution and License Agreement shall be deemed a separate and complete<br \/>\nagreement and shall exist and be governed independent of this Agreement.<\/p>\n<p>            10.14 Specific Performance.<\/p>\n<p>            Each of the Parties acknowledges and agrees that the other Parties<br \/>\nwould be damaged irreparably in the event any of the provisions of this<br \/>\nAgreement are not performed in accordance with their specific terms or otherwise<br \/>\nare breached. Accordingly, each of the Parties agrees that the other Parties<br \/>\nshall be entitled to an injunction or injunctions to prevent breaches of the<br \/>\nprovisions of this Agreement and to enforce specifically this Agreement and the<br \/>\nterms and provisions hereof in any action instituted in any court of the United<br \/>\nStates or any state thereof having jurisdiction over the Parties and the matter<br \/>\n(subject to the provisions set forth in Section 10.15 below), in addition to<br \/>\nany other remedy to which they may be entitled, at law or in equity.<\/p>\n<p>            10.15 Submission to Jurisdiction.<\/p>\n<p>            Each of the Parties submits to the jurisdiction of any state or<br \/>\nfederal court sitting in Orange County, California, in any action or proceeding<br \/>\narising out of or relating to this Agreement<\/p>\n<p>                                       30<br \/>\n   35<br \/>\nand agrees that all claims in respect of the action or proceeding may be heard<br \/>\nand determined in any such court. Each Party also agrees not to bring any action<br \/>\nor proceeding arising out of or relating to this Agreement in any other court.<br \/>\nEach of the Parties waives any defense of inconvenient forum to the maintenance<br \/>\nof any action or proceeding so brought and waives any bond, surety, or other<br \/>\nsecurity that might be required of any other Party with respect thereto. Any<br \/>\nParty may make service on any other Party by sending or delivering a copy of the<br \/>\nprocess to the Party to be served at the address and in the manner provided for<br \/>\nthe giving of notices in Section 10.7 above.<\/p>\n<p>            10.16 Confidentiality.<\/p>\n<p>            Each of the Parties and their respective representatives and<br \/>\nemployees shall keep strictly confidential and shall not disclose or use for any<br \/>\npurpose other than this Agreement, any and all confidential and proprietary<br \/>\ninformation (&#8216;Confidential Information&#8217;) disclosed by any of the Parties (an<br \/>\n&#8216;Informing Party&#8217;) to any other Party (an &#8216;Informed Party&#8217;) or learned by the<br \/>\nInformed Party from the premises, properties, personnel, books, records<br \/>\n(including Tax records), contracts, and documents to which it is given access.<br \/>\nEach Party shall limit disclosure of Confidential Information to its<br \/>\nrepresentatives, financial advisors and employees on a need to know basis. The<br \/>\nterm &#8216;Confidential Information&#8217; does not include information which (i) is or<br \/>\nbecomes generally available to the public other than as a result of a disclosure<br \/>\nby the Informed Party or its representatives, (ii) was available to the Informed<br \/>\nParty on a non-confidential basis prior to its disclosure to the Informed Party<br \/>\nby the Informing Party or its representatives, or (iii) becomes available to the<br \/>\nInformed Party on a non-confidential basis from a source other than the<br \/>\nInforming Party or its representatives, provided, however, that such source is<br \/>\nnot bound by a confidentiality agreement with the Informing Party or its<br \/>\nrepresentatives. Each of the Parties shall ensure that its representatives and<br \/>\nemployees comply with this Section 10.16.<\/p>\n<p>            10.17 California Corporate State Securities Law.<\/p>\n<p>            THE SALE OF THE SECURITIES WHICH ARE THE SUBJECT OF THIS AGREEMENT<br \/>\nHAS NOT BEEN QUALIFIED WITH THE COMMISSIONER OF CORPORATIONS OF THE STATE OF<br \/>\nCALIFORNIA OR UTAH AND THE ISSUANCE OF SUCH SECURITIES OR THE PAYMENT OR RECEIPT<br \/>\nOF ANY PART OF THE CONSIDERATION FOR SUCH SECURITIES PRIOR TO SUCH QUALIFICATION<br \/>\nIS UNLAWFUL, UNLESS THE SALE OF SECURITIES IS EXEMPT FROM QUALIFICATION BY<br \/>\nSECTION 25100, 25102 OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF<br \/>\nALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON SUCH QUALIFICATION<br \/>\nBEING OBTAINED, UNLESS THE SALE IS SO EXEMPT.<\/p>\n<p>                                       31<br \/>\n   36<br \/>\n      IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of<br \/>\nthe date first above written.<\/p>\n<p>                     MTI TECHNOLOGY CORPORATION, a Delaware<br \/>\n                     corporation<\/p>\n<p>                     By:  \/s\/ DALE R. BORD<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                     Title: Chief Financial Officer<\/p>\n<p>                     CALDERA SYSTEMS, INC., a Utah corporation<\/p>\n<p>                     By: \/s\/ RANSOM H. LOVE<br \/>\n                        &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n                     Title: President &amp; CEO<\/p>\n<p>                    THE CANOPY GROUP, INC., a Utah corporation<\/p>\n<p>                     By: \/s\/ RALPH YARRO<br \/>\n                        &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n                     Title: President &amp; CEO<\/p>\n<p>                                       32<\/p>\n","protected":false},"template":"","meta":{"_acf_changed":false,"_stopmodifiedupdate":true,"_modified_date":"","_cloudinary_featured_overwrite":false},"corporate_contracts_companies":[6993],"corporate_contracts_industries":[9513],"corporate_contracts_types":[9622,9627],"class_list":["post-43696","corporate_contracts","type-corporate_contracts","status-publish","hentry","corporate_contracts_companies-caldera-systems-inc","corporate_contracts_industries-technology__software","corporate_contracts_types-planning","corporate_contracts_types-planning__purchase"],"acf":[],"_links":{"self":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts\/43696","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts"}],"about":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/types\/corporate_contracts"}],"wp:attachment":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/media?parent=43696"}],"wp:term":[{"taxonomy":"corporate_contracts_companies","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_companies?post=43696"},{"taxonomy":"corporate_contracts_industries","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_industries?post=43696"},{"taxonomy":"corporate_contracts_types","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_types?post=43696"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}